Klebsiella pneumoniae (DSM 681, ATCC 10031, NCIB 9111)

Name: Klebsiella pneumoniae (DSM 681, ATCC 10031, NCIB 9111)
Creator: BacDive
License: http://creativecommons.org/licenses/by/4.0/

BacDive ID 4968

Type strain

Culture col. no. DSM 681 ATCC 10031 NCIB 9111 NCTC 7427 CCUG 10785 4 more

NCBI tax ID(s) 573

Special Collections DSMZ CCUG CIP

History <- NCTC; NCTC 7427 (Klebsiella aerogenes) <- ATCC; ATCC 10031 <- U.S. Food and Drug Administration (FDA), Washington, D.C., USA; PCI 602 CIP <- 1953, ATCC <- W.A. Randall, FDA, Washington, USA: strain PCI 602

Links

Klebsiella pneumoniae DSM 681 is an aerobe, Gram-negative, rod-shaped bacterium of the family Enterobacteriaceae.

Gram-negative rod-shaped aerobe genome sequence 16S sequence Bacteria

Name and taxonomic classification

SI-ID 10831

LMG 8200,ATCC 10031,CECT 142,IFO 3512,LMG 3164,NCIMB 9111,NCTC 7427,NCIB 9111,CCUG 10785,CCM 4415,CIP 53.153,CIP 54.128,CCRC 11546,NBRC 3512,BCRC 11546,ICMP 5925,NBIMCC 1058,NCAIM B.01686,CDBB 1024,ACM 5056,CNCTC 6119,DSM 681

@ref 20215

Last LPSN update 2026-02-09 11:18:51

Domain Bacteria

Phylum Pseudomonadota

Class Gammaproteobacteria

Order Enterobacterales

Family Enterobacteriaceae

Genus Klebsiella

Species Klebsiella pneumoniae

Full scientific name Klebsiella pneumoniae (Schroeter 1886) Trevisan 1887 (Approved Lists 1980)

Synonyms (1)

"Hyalococcus pneumoniae"

BacDive ID	Other strains from **Klebsiella pneumoniae** (329)	Type strain
4946	K. pneumoniae A, DSM 1620
4947	K. pneumoniae DSM 1643, BMTU 5
4948	K. pneumoniae 240, DSM 2026, ATCC 15380, NCIB 418, NCTC ...
4949	K. pneumoniae H 273, DSM 4270
4950	K. pneumoniae PZH, DSM 4799, ATCC 25955, PZH 572
4951	K. pneumoniae 62-1, DSM 5758, ATCC 25306, DSM 1470
4952	K. pneumoniae WS 1758, DSM 6135
4956	K. pneumoniae GT1, DSM 12082
4957	K. pneumoniae 10-04-09, B02624, DSM 16609
4961	K. pneumoniae DSM 25721, NCCP 13840
4962	K. pneumoniae K6, MCV37, DSM 26371, ATCC 700603, CCUG 45421, ...
4964	K. pneumoniae ASR1, DSM 15998
4969	K. pneumoniae CCUG 58866, DSM 789, ATCC 4352, NCIB 10341, ...
100251	K. pneumoniae ST033303(HKI),
23932	K. pneumoniae K. pneumoniae 63, DSM 12059, ICB 6370
131036	K. pneumoniae DSM 24075, WB 2
131729	K. pneumoniae T2-1-1, DSM 102039
131730	K. pneumoniae 102027, T2-1-2, DSM 102040
131731	K. pneumoniae 789, DSM 103517
131732	K. pneumoniae 769, DSM 103518
132747	K. pneumoniae pC1, DSM 15563
132748	K. pneumoniae pC4, DSM 15565
134420	K. pneumoniae CIP 53.22, BR 38
134455	K. pneumoniae KPLA-1, CIP 105705
134462	K. pneumoniae RYC492, CIP 105659, NCTC 50149
134464	K. pneumoniae KPZU-12, CIP 105704
134583	K. pneumoniae 11, CIP 106641
134586	K. pneumoniae 21, CIP 106685
134604	K. pneumoniae MCQ-112, CIP 106982
134621	K. pneumoniae CIP 60.69, NCIMB 10197
134765	K. pneumoniae CIP 60.70, NCIMB 10198
135130	K. pneumoniae Mich. 61, CIP 52.219
135282	K. pneumoniae 1296, CIP 100633, ATCC 27799
135414	K. pneumoniae RP 1, CIP 104118
135415	K. pneumoniae RP 10, CIP 104119
135417	K. pneumoniae RP 24, CIP 104120
135814	K. pneumoniae 625, 5, CIP 80.42
135867	K. pneumoniae CIP 53.23, BR 39
135872	K. pneumoniae CIP 53.25
135918	K. pneumoniae TP 02, CIP 105869
135924	K. pneumoniae 10, M44, CIP 106167
135936	K. pneumoniae ORI-1, CIP 106818
136009	K. pneumoniae 740.84, CIP 101114
136158	K. pneumoniae 4715/50, CIP 52.201
136161	K. pneumoniae B7380, CIP 52.204, ATCC 7380
136163	K. pneumoniae CIP 52.205, NCTC 4140
136165	K. pneumoniae 1015, CIP 52.206
136175	K. pneumoniae SB3245, CIP 52.214
136176	K. pneumoniae 390, CIP 52.215
136179	K. pneumoniae 138, CIP 52.218
136182	K. pneumoniae 2069/49, CIP 52.220
136186	K. pneumoniae 1754/49, CIP 52.222
136187	K. pneumoniae 293/50, CIP 52.223
136188	K. pneumoniae K20, CIP 52.224
136190	K. pneumoniae 1702/49, CIP 52.225
136191	K. pneumoniae 1996/49, CIP 52.226
136193	K. pneumoniae 1680/49, CIP 52.229
136194	K. pneumoniae CIP 52.231, BR 21
136196	K. pneumoniae CIP 52.230, NCTC 9145
136199	K. pneumoniae CIP 52.232, BR 16
136200	K. pneumoniae CIP 52.233, BR 17
136203	K. pneumoniae CIP 52.235, BR 19
136214	K. pneumoniae 97-52, UA 600, CIP 103522
136216	K. pneumoniae CIP 53.17, BR 33
136219	K. pneumoniae CIP 53.8, BR 23
136223	K. pneumoniae CIP 53.11, BR 26
136224	K. pneumoniae CIP 53.12, BR 27
136228	K. pneumoniae CIP 53.15, BR 31
136231	K. pneumoniae AmMS 249, CIP 103623, ATCC 49472
136294	K. pneumoniae 5657, CIP 104298
136451	K. pneumoniae CF 704, CIP 105856
136452	K. pneumoniae CF 2104, CIP 105857
136491	K. pneumoniae M176, 37, CIP 106194
136542	K. pneumoniae 41, CIP 54.128
136546	K. pneumoniae Kp 4940, CIP 106670
136621	K. pneumoniae NHRI 1001, CIP 107112
136939	K. pneumoniae SB 501, 5710/52, CIP 108293
137091	K. pneumoniae 313, CIP 52.216
137155	K. pneumoniae 21, 628, CIP 80.44
137156	K. pneumoniae 629, 24, CIP 80.45
137160	K. pneumoniae C 5046, CIP 52.146, NCTC 5056
137232	K. pneumoniae 916, CIP 52.208
137234	K. pneumoniae CIP 52.217, BR 13
137241	K. pneumoniae 2812/50, CIP 52.228
137246	K. pneumoniae CIP 53.13, BR 28
137249	K. pneumoniae CIP 53.14, BR 29
137253	K. pneumoniae CIP 53.21, BR 36
137392	K. pneumoniae P20, CIP 104341
137609	K. pneumoniae OM1, 700, CIP 80.46
137610	K. pneumoniae OM26, 6701, CIP 80.47
137611	K. pneumoniae 703, CIP 80.48, QM 56
137700	K. pneumoniae 624, 12, CIP 80.41
138008	K. pneumoniae F1, CIP 52.144, ATCC 13886, NCTC 5054, CCUG ...
138125	K. pneumoniae 87 B-1, CIP 104901
138181	K. pneumoniae MCQ-122, CIP 105166
138362	K. pneumoniae SLK 54, CIP 106769
138364	K. pneumoniae HM08G, CIP 106905
138391	K. pneumoniae 45956, CIP 106976
138440	K. pneumoniae B 5055, CIP 52.145, NCTC 5055
138460	K. pneumoniae 2005/49, CIP 52.221
138507	K. pneumoniae chalazion, CIP A215
138583	K. pneumoniae NB 37, CIP 104039
138657	K. pneumoniae CIP 53.19, BR 34
138771	K. pneumoniae 1056, CIP 52.207
138822	K. pneumoniae LRA 003 09 73, CIP 103687, ATCC 23357
138846	K. pneumoniae Korski, CIP 58.5
139193	K. pneumoniae Innsbruck A-1, CIP 104727
139204	K. pneumoniae 2918381, CIP 104771
139234	K. pneumoniae CIP 53.9, BR 24
139277	K. pneumoniae CF 1304, CIP 105858
139285	K. pneumoniae TP 01, CIP 105868
139321	K. pneumoniae 75, CIP 106231
139425	K. pneumoniae KC100, CIP 110652, KCTC 2242
139426	K. pneumoniae CIP 110798, NCTC 11228, ATCC 29665, CCUG ...
141536	K. pneumoniae CCUG 2715
141748	K. pneumoniae CCUG 6006
141749	K. pneumoniae CCUG 6007
141761	K. pneumoniae CCUG 6507, NCTC 10896
142969	K. pneumoniae CCUG 15954
144300	K. pneumoniae CCUG 24250
144504	K. pneumoniae CCUG 25403
144507	K. pneumoniae CCUG 25408
144508	K. pneumoniae CCUG 25414
144510	K. pneumoniae CCUG 25426
144511	K. pneumoniae CCUG 25431
144525	K. pneumoniae CCUG 25492
144655	K. pneumoniae CCUG 26108
144834	K. pneumoniae CCUG 26733
144835	K. pneumoniae CCUG 26734
144836	K. pneumoniae CCUG 26735
145009	K. pneumoniae CCUG 27395
145416	K. pneumoniae CCUG 28420
145807	K. pneumoniae CCUG 29646
145964	K. pneumoniae CCUG 29970
146278	K. pneumoniae CCUG 30779
146621	K. pneumoniae CCUG 31617, NCTC 7242
147217	K. pneumoniae CCUG 33079
148038	K. pneumoniae CCUG 34718
148195	K. pneumoniae CCUG 35020
148449	K. pneumoniae CCUG 35461
148516	K. pneumoniae CCUG 35581
148980	K. pneumoniae CCUG 36675
149272	K. pneumoniae CCUG 37387
149273	K. pneumoniae CCUG 37388
149365	K. pneumoniae CCUG 37597
150227	K. pneumoniae CCUG 39327
151280	K. pneumoniae CCUG 43603
151760	K. pneumoniae CCUG 44810
151873	K. pneumoniae CCUG 45102
151876	K. pneumoniae CCUG 45105
153240	K. pneumoniae CCUG 48848
153328	K. pneumoniae CCUG 49243
154224	K. pneumoniae CCUG 52804
154229	K. pneumoniae CCUG 52846
154642	K. pneumoniae CCUG 54718
154869	K. pneumoniae CCUG 55505
155043	K. pneumoniae CCUG 56233
155636	K. pneumoniae CCUG 58545
155637	K. pneumoniae CCUG 58546
155638	K. pneumoniae CCUG 58547
155806	K. pneumoniae CCUG 59348
155807	K. pneumoniae CCUG 59349
155808	K. pneumoniae CCUG 59350
155816	K. pneumoniae CCUG 59358
155817	K. pneumoniae CCUG 59359
155818	K. pneumoniae CCUG 59360
155830	K. pneumoniae CCUG 59413
156033	K. pneumoniae CCUG 60138
156059	K. pneumoniae CCUG 60237
156089	K. pneumoniae CCUG 60349
156444	K. pneumoniae CCUG 61815
156658	K. pneumoniae CCUG 63957
156721	K. pneumoniae CCUG 64452
156866	K. pneumoniae CCUG 66189
157025	K. pneumoniae CCUG 68727, NCTC 13442
157026	K. pneumoniae NCTC 13443, CCUG 68728
157926	K. pneumoniae Kp-Goe-33208, Kp_Goe_33208, DSM 103696
157927	K. pneumoniae Kp-Goe-39795, Kp_Goe_39795, DSM 103697
157928	K. pneumoniae Kp-Goe-62629, Kp_Goe_62629, DSM 103698
157929	K. pneumoniae Kp-Goe-71070, Kp_Goe_71070, DSM 103699
157930	K. pneumoniae Kp-Goe-821588, Kp_Goe_821588, DSM 103700
157931	K. pneumoniae Kp-Goe-822579, Kp_Goe_822579, DSM 103701
157932	K. pneumoniae Kp-Goe-822917, Kp_Goe_822917, DSM 103702
157933	K. pneumoniae Kp-Goe-825795, Kp_Goe_825795, DSM 103703
157934	K. pneumoniae Kp-Goe-827024, Kp_Goe_827024, DSM 103704
157935	K. pneumoniae Kp-Goe-827026, Kp_Goe_827026, DSM 103705
157936	K. pneumoniae Kp-Goe-828304, Kp_Goe_828304, DSM 103706
157937	K. pneumoniae Kp-Goe-121641, Kp_Goe_121641, DSM 103707
157938	K. pneumoniae Kp-Goe-149473, Kp_Goe_149473, DSM 103708
157939	K. pneumoniae Kp-Goe-149832, Kp_Goe_149832, DSM 103709
157940	K. pneumoniae Kp-Goe-152021, Kp_Goe_152021, DSM 103710
157941	K. pneumoniae Kp-Goe-154414, Kp_Goe_154414, DSM 103711
159215	K. pneumoniae BWKH 500, DSM 109288
159216	K. pneumoniae BWKH 501, DSM 109289
159217	K. pneumoniae BWKH 502, DSM 109290
159218	K. pneumoniae BWKH 504, DSM 109291
159219	K. pneumoniae BWKH 506, DSM 109292
159220	K. pneumoniae BWKH 507, DSM 109293
159221	K. pneumoniae BWKH 510, DSM 109294
159222	K. pneumoniae BWKH 511, DSM 109295
159223	K. pneumoniae BWKH 514, DSM 109296
159224	K. pneumoniae BWKH 516, DSM 109297
159225	K. pneumoniae BWKH 517, DSM 109298
159226	K. pneumoniae BWKH 518, DSM 109299
159227	K. pneumoniae BWKH 520, DSM 109300
159228	K. pneumoniae BWKH 522, DSM 109301
159229	K. pneumoniae BWKH 523, DSM 109302
159230	K. pneumoniae BWKH 525, DSM 109303
159231	K. pneumoniae BWKH 387, DSM 109306
159232	K. pneumoniae BWKH 388, DSM 109307
159233	K. pneumoniae BWKH 390, DSM 109308
159234	K. pneumoniae BWKH 391, DSM 109309
159235	K. pneumoniae BWKH 393, DSM 109310
159236	K. pneumoniae BWKH 395, DSM 109311
159237	K. pneumoniae BWKH 396, DSM 109312
159238	K. pneumoniae BWKH 397, DSM 109313
159239	K. pneumoniae BWKH 398, DSM 109314
159240	K. pneumoniae BWKH 399, DSM 109315
159241	K. pneumoniae BWKH 401, DSM 109316
159242	K. pneumoniae BWKH 402, DSM 109317
159243	K. pneumoniae BWKH 403, DSM 109318
159244	K. pneumoniae BWKH 404, DSM 109319
159245	K. pneumoniae BWKH 406, DSM 109320
159246	K. pneumoniae BWKH 407, DSM 109321
159247	K. pneumoniae BWKH 410, DSM 109322
159248	K. pneumoniae BWKH 411, DSM 109323
159249	K. pneumoniae BWKH 412, DSM 109324
159250	K. pneumoniae BWKH 413, DSM 109325
159251	K. pneumoniae BWKH 415, DSM 109326
159252	K. pneumoniae BWKH 416, DSM 109327
159253	K. pneumoniae BWKH 421, DSM 109328
159254	K. pneumoniae BWKH 424, DSM 109329
159255	K. pneumoniae BWKH 425, DSM 109330
159256	K. pneumoniae BWKH 428, DSM 109331
159257	K. pneumoniae BWKH 429, DSM 109332
159258	K. pneumoniae BWKH 430, DSM 109333
159259	K. pneumoniae BWKH 485, DSM 109434
159260	K. pneumoniae BWKH 432, DSM 109334
159261	K. pneumoniae BWKH 433, DSM 109335
159262	K. pneumoniae BWKH 434, DSM 109336
159263	K. pneumoniae BWKH 435, DSM 109337
159264	K. pneumoniae BWKH 439, DSM 109338
159265	K. pneumoniae BWKH 440, DSM 109339
159266	K. pneumoniae BWKH 441, DSM 109340
159267	K. pneumoniae BWKH 442, DSM 109341
159268	K. pneumoniae BWKH 443, DSM 109363
159269	K. pneumoniae BWKH 444, DSM 109364
159270	K. pneumoniae BWKH 445, DSM 109365
159271	K. pneumoniae BWKH 446, DSM 109366
159272	K. pneumoniae BWKH 448, DSM 109367
159273	K. pneumoniae BWKH 449, DSM 109368
159274	K. pneumoniae BWKH 450, DSM 109369
159275	K. pneumoniae BWKH 451, DSM 109370
159276	K. pneumoniae BWKH 452, DSM 109371
159277	K. pneumoniae BWKH 453, DSM 109372
159278	K. pneumoniae BWKH 454, DSM 109373
159279	K. pneumoniae BWKH 457, DSM 109383
159280	K. pneumoniae BWKH 458, DSM 109384
159281	K. pneumoniae BWKH 459, DSM 109385
159282	K. pneumoniae BWKH 460, DSM 109386
159283	K. pneumoniae BWKH 461, DSM 109387
159284	K. pneumoniae BWKH 462, DSM 109388
159285	K. pneumoniae BWKH 463, DSM 109389
159286	K. pneumoniae BWKH 466, DSM 109390
159287	K. pneumoniae BWKH 467, DSM 109391
159288	K. pneumoniae BWKH 468, DSM 109392
159289	K. pneumoniae BWKH 469, DSM 109393
159290	K. pneumoniae BWKH 470, DSM 109394
159291	K. pneumoniae BWKH 471, DSM 109395
159292	K. pneumoniae BWKH 473, DSM 109396
159293	K. pneumoniae BWKH 456, DSM 109374
159294	K. pneumoniae BWKH 475, DSM 109397
159295	K. pneumoniae BWKH 476, DSM 109398
159296	K. pneumoniae BWKH 477, DSM 109426
159297	K. pneumoniae BWKH 478, DSM 109427
159298	K. pneumoniae BWKH 479, DSM 109428
159299	K. pneumoniae BWKH 480, DSM 109429
159300	K. pneumoniae BWKH 481, DSM 109430
159301	K. pneumoniae BWKH 482, DSM 109431
159302	K. pneumoniae BWKH 483, DSM 109432
159303	K. pneumoniae BWKH 484, DSM 109433
159304	K. pneumoniae BWKH 490, DSM 109435
159305	K. pneumoniae BWKH 492, DSM 109436
159306	K. pneumoniae BWKH 494, DSM 109437
159307	K. pneumoniae BWKH 496, DSM 109438
159308	K. pneumoniae BWKH 497, DSM 109439
159309	K. pneumoniae BWKH 498, DSM 109440
164070	K. pneumoniae JCM 31465
169368	K. pneumoniae 108453, DSM 108453
169369	K. pneumoniae 235-11, DSM 113479
173492	K. pneumoniae Kp B, CIP 78.23
173493	K. pneumoniae Caroli, CIP 78.24
173494	K. pneumoniae Kn1 Lyon, CIP 78.25
173495	K. pneumoniae KP21, CRBIP19.50
173496	K. pneumoniae SB20, 04A025, CIP 111841
173497	K. pneumoniae SB1139, CIP 111853
173498	K. pneumoniae SB4-2, CIP 111863
173499	K. pneumoniae SB617, CIP 111865, CRBIP28.80
173500	K. pneumoniae SB612, 2-3, CIP 111888
174880	K. pneumoniae 112836, DSM 112836
174881	K. pneumoniae 112838, DSM 112838
174882	K. pneumoniae 112839, DSM 112839
174883	K. pneumoniae 112847, DSM 112847
174884	K. pneumoniae TX 2493, DSM 115737
174885	K. pneumoniae TX 5016, DSM 115751
174886	K. pneumoniae KPC1_111, DSM 116097
174887	K. pneumoniae KPC1_104, DSM 116098
174888	K. pneumoniae KPC1_112, DSM 116099
174889	K. pneumoniae KPC1_113, DSM 116100
174890	K. pneumoniae KPC1_147, DSM 116107
174891	K. pneumoniae KPC1_151, DSM 116108
174892	K. pneumoniae KPC1_181, DSM 116109
174893	K. pneumoniae DSM 116618, NCCP 15864
174894	K. pneumoniae DSM 116619, NCCP 15866
174895	K. pneumoniae DSM 116620, NCCP 16124
174896	K. pneumoniae DSM 116621, NCCP 16212
174897	K. pneumoniae 2742, TX 2742, DSM 117616
174898	K. pneumoniae 3552, TX 3552, DSM 118096
174899	K. pneumoniae 3630, TX 3630, DSM 118098
174900	K. pneumoniae 3911, TX 3911, DSM 118101
174901	K. pneumoniae 4295, DSM 118104
174902	K. pneumoniae 4487, TX 4487, DSM 118265
174903	K. pneumoniae 4662, TX 4662, DSM 118266
174904	K. pneumoniae 5087, DSM 118277
176703	K. pneumoniae KB_Kp057, DSM 117136
176704	K. pneumoniae CN_Kp090, DSM 117137
176705	K. pneumoniae CN_Kp094, DSM 117138
176706	K. pneumoniae CN_Kp107, DSM 117139
176707	K. pneumoniae CN_Kp115, DSM 117140

Morphology

Cell morphology

@ref	Gram stain	Cell shape	Confidence
121888	negative	rod-shaped
125438	negative		99.5
125439	negative		98.2

Culture and growth conditions

Culture medium

@ref	Name	Medium link	Composition
357	COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)	Medium recipe at MediaDive	Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
37328	MEDIUM 3 - Columbia agar		Columbia agar (39.000 g);distilled water (1000.000 ml)
121888	CIP Medium 72	Medium recipe at CIP
121888	CIP Medium 3	Medium recipe at CIP
357	TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)	Medium recipe at MediaDive	Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water

Culture temp

@ref	Growth	Type	Temperature (°C)
357	positive	growth	37
37328	positive	growth	30
45338	positive	growth	37
121888	positive	growth	30-41
121888	negative	growth	5
121888	negative	growth	10

Physiology and metabolism

Oxygen tolerance

@ref	Oxygen tolerance	Confidence
45338	aerobe
121888	facultative anaerobe
125439	aerobe	95.3

Antibiotic susceptibility testing

	Test 1	Test 2	Test 3	Test 4	Test 5
@ref	357	357	357	357	357
Medium	Mueller-Hinton Agar	Mueller-Hinton Agar	Mueller-Hinton Agar	Mueller-Hinton Agar	Müller-Hinton Agar
Manual annotation	1	1	1	1	1
	Inhibition zone diameter in mm	Inhibition zone diameter in mm	Inhibition zone diameter in mm	Inhibition zone diameter in mm	Inhibition zone diameter in mm
Amikacin 30µg (disc)	24	26	26	24	26
Ampicillin 10µg (disc)	14	10-12	10-12	10	12
Aztreonam 30µg (disc)	40-42	38	38	38	40
Bacitracin 10Unit	0	0	0	0	n.d.
Cefalotin 30µg (disc)	32	30	30	30	n.d.
Cefazolin 30µg (disc)	28-30	28	28	28	n.d.
Cefiderocol 30µg (disc)	n.d.	n.d.	n.d.	n.d.	36
Cefotaxime 30µg (disc)	42	42	42	42	44
Ceftazidime 10µg (disc)	n.d.	n.d.	n.d.	n.d.	32-34
Ceftriaxone 30µg (disc)	38-40	34	34	36	40
Chloramphenicol 30µg (disc)	36	34	34	36	38
Ciprofloxacin 5µg (disc)	n.d.	n.d.	n.d.	n.d.	42
Clindamycin 10µg (disc)	20-22	20	20	20	18-20
Colistin 10µg (disc)	14	14	14	14	n.d.
Colistin sulphate 10µg (disc)	n.d.	n.d.	n.d.	n.d.	14
Doxycycline 30µg (disc)	28-30	28	28	28	n.d.
Erythromycin 15µg (disc)	20	20	20	20	20-22
Fosfomycin 50µg (disc)	24-26	26	26	26-28	26
Gentamicin 30µg (disc)	n.d.	n.d.	n.d.	n.d.	22
Gentamycin 10µg (disc)					n.d.
Imipenem 10µg (disc)	30	30	30	30-32	32
Kanamycin 30µg (disc)	24-26	26	26	24	26
Levofloxacin 5µg (disc)	n.d.	n.d.	n.d.	n.d.	40
Lincomycin 15µg (disc)	8-10	8	8	8-10	n.d.
Linezolid 10µg (disc)	20	20	20	22	22
Meropenem 10µg (disc)	n.d.	n.d.	n.d.	n.d.	38
Mezlocillin 30µg (disc)	24-26	24	24	24-26	n.d.
Moxifloxacin 5µg (disc)	36-38	34	34	36	38
Neomycin 30µg (disc)	20	20	20	18-20	n.d.
Nitrofurantoin 100µg (disc)	24	22	22	22	24
Norfloxacin 10µg (disc)	36	34	34	36-38	n.d.
Nystatin 100Unit	0	0	0	0	n.d.
Ofloxacin 5µg (disc)	38	34	34	38	38-40
Oxacillin 5µg (disc)	12	12	12	10-12	14
Penicillin G 6µg (disc)	10	6	6	0	6
Pipemidic acid 20µg (disc)	26	26	26	26-28	n.d.
Piperacillin/Tazobactam 40µg (disc)	30	30	30	32	n.d.
Piperacillin/Tazobactam 110µg (disc)	n.d.	n.d.	n.d.	n.d.	34
Polymyxin B 300Unit	14	16	16	16	16
Quinupristin/Dalfopristin 15µg (disc)	10	8-10	8-10	6	10
Rifampicin 5µg (disc)	n.d.	n.d.	n.d.	n.d.	10
Teicoplanin 30µg (disc)	0	0	0	0	0
Tetracycline 30µg (disc)	28-30	30	30	30	30
Ticarcillin 75µg (disc)	14	14	14	12	14
Tigecycline 15µg (disc)	n.d.	n.d.	n.d.	n.d.	26
Trimethoprim-sulfamethoxazole (1:19) 10µg (disc)	n.d.	n.d.	n.d.	n.d.	32
Vancomycin 30µg (disc)	8	0	0	0	0

Spore formation

@ref	Spore formation	Confidence
125439		91.1

Compound production

@ref	Compound
357	D ribulokinase
20216	D-Ribulokinase
20216	quality control

Metabolite utilization

@ref	Chebi-ID	Metabolite	Utilization activity	Kind of utilization tested
68368	27613 ChEBI	amygdalin	+	fermentation	from API 20E
68374	29016 ChEBI	arginine	-	hydrolysis	from API ID32E
68368	29016 ChEBI	arginine	-	hydrolysis	from API 20E
68374	17057 ChEBI	cellobiose	+	builds acid from	from API ID32E
121888	16947 ChEBI	citrate	+	carbon source
68374	18333 ChEBI	D-arabitol	+	builds acid from	from API ID32E
68374	18024 ChEBI	D-galacturonic acid	+	builds acid from	from API ID32E
68374	17634 ChEBI	D-glucose	+	builds acid from	from API ID32E
68368	17634 ChEBI	D-glucose	+	fermentation	from API 20E
68374	16899 ChEBI	D-mannitol	+	builds acid from	from API ID32E
68368	16899 ChEBI	D-mannitol	+	fermentation	from API 20E
68368	5291 ChEBI	gelatin	-	hydrolysis	from API 20E
121888	17234 ChEBI	glucose	+	fermentation
121888	17234 ChEBI	glucose	+	degradation
68374	30849 ChEBI	L-arabinose	+	builds acid from	from API ID32E
68368	30849 ChEBI	L-arabinose	+	fermentation	from API 20E
68374	18403 ChEBI	L-arabitol	-	builds acid from	from API ID32E
68374	62345 ChEBI	L-rhamnose	+	builds acid from	from API ID32E
68368	62345 ChEBI	L-rhamnose	+	fermentation	from API 20E
121888	17716 ChEBI	lactose	+	fermentation
68374	25094 ChEBI	lysine	+	degradation	from API ID32E
68374	15792 ChEBI	malonate	-	assimilation	from API ID32E
68374	17306 ChEBI	maltose	+	builds acid from	from API ID32E
121888	29864 ChEBI	mannitol	+	fermentation
68368	28053 ChEBI	melibiose	+	fermentation	from API 20E
68374	17268 ChEBI	myo-inositol	+	builds acid from	from API ID32E
68368	17268 ChEBI	myo-inositol	+	fermentation	from API 20E
121888	17632 ChEBI	nitrate	+	reduction
121888	16301 ChEBI	nitrite	+	reduction
68374	18257 ChEBI	ornithine	-	degradation	from API ID32E
68368	18257 ChEBI	ornithine	-	degradation	from API 20E
68374	18394 ChEBI	palatinose	+	builds acid from	from API ID32E
68374		Potassium 5-ketogluconate	-	builds acid from	from API ID32E
68374	15963 ChEBI	ribitol	+	builds acid from	from API ID32E
121888	132112 ChEBI	sodium thiosulfate	-	builds gas from
68374	30911 ChEBI	sorbitol	+	builds acid from	from API ID32E
68368	30911 ChEBI	sorbitol	+	fermentation	from API 20E
68374	17992 ChEBI	sucrose	+	builds acid from	from API ID32E
68368	17992 ChEBI	sucrose	+	fermentation	from API 20E
68374	27082 ChEBI	trehalose	+	builds acid from	from API ID32E
68374	27897 ChEBI	tryptophan	-	energy source	from API ID32E
68368	27897 ChEBI	tryptophan	-	energy source	from API 20E
68374	16199 ChEBI	urea	+	hydrolysis	from API ID32E

Antibiotic resistance

@ref	ChEBI	Metabolite	Resistance conc.
121888		0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
357	28669	Bacitracin	10 Unit	from Antibiotic test
357	7660	Nystatin	100 Unit	from Antibiotic test
357	29687	Teicoplanin	30 µg (disc)	from Antibiotic test

Metabolite production

@ref	Chebi-ID	Metabolite
68368	16136 ChEBI	hydrogen sulfide	from API 20E
68374	35581 ChEBI	indole	from API ID32E
121888	35581 ChEBI	indole
68368	35581 ChEBI	indole	from API 20E

Metabolite tests

@ref	Chebi-ID	Metabolite	Indole test	Voges-proskauer-test	Methylred-test
121888	15688 ChEBI	acetoin		+
121888	17234 ChEBI	glucose			-
68374	35581 ChEBI	indole	-			from API ID32E
68368	35581 ChEBI	indole	-			from API 20E

Enzymes

@ref	Value	Activity	Ec
68382	acid phosphatase	+	3.1.3.2	from API zym
121888	alcohol dehydrogenase	-	1.1.1.1
68382	alkaline phosphatase	+	3.1.3.1	from API zym
68382	alpha-chymotrypsin	-	3.4.21.1	from API zym
68382	alpha-fucosidase	-	3.2.1.51	from API zym
68382	alpha-galactosidase	+	3.2.1.22	from API zym
68374	alpha-galactosidase	+	3.2.1.22	from API ID32E
68382	alpha-glucosidase	+	3.2.1.20	from API zym
68374	alpha-glucosidase	-	3.2.1.20	from API ID32E
68374	alpha-maltosidase	-		from API ID32E
68382	alpha-mannosidase	-	3.2.1.24	from API zym
68374	arginine dihydrolase	-	3.5.3.6	from API ID32E
68368	arginine dihydrolase	-	3.5.3.6	from API 20E
68382	beta-galactosidase	+	3.2.1.23	from API zym
121888	beta-galactosidase	+	3.2.1.23
68374	beta-galactosidase	+	3.2.1.23	from API ID32E
68368	beta-galactosidase	+	3.2.1.23	from API 20E
68382	beta-glucosidase	+	3.2.1.21	from API zym
68374	beta-glucosidase	+	3.2.1.21	from API ID32E
68382	beta-glucuronidase	-	3.2.1.31	from API zym
68374	beta-glucuronidase	-	3.2.1.31	from API ID32E
121888	catalase	+	1.11.1.6
68382	cystine arylamidase	-	3.4.11.3	from API zym
68368	cytochrome oxidase	-	1.9.3.1	from API 20E
68382	esterase (C 4)	+		from API zym
68382	esterase lipase (C 8)	+		from API zym
121888	gelatinase	-
68368	gelatinase	-		from API 20E
68374	L-aspartate arylamidase	-	3.4.11.21	from API ID32E
68382	leucine arylamidase	+	3.4.11.1	from API zym
68374	lipase	-		from API ID32E
68382	lipase (C 14)	-		from API zym
121888	lysine decarboxylase	+	4.1.1.18
68374	lysine decarboxylase	+	4.1.1.18	from API ID32E
68382	N-acetyl-beta-glucosaminidase	-	3.2.1.52	from API zym
68374	N-acetyl-beta-glucosaminidase	-	3.2.1.52	from API ID32E
68382	naphthol-AS-BI-phosphohydrolase	+		from API zym
121888	ornithine decarboxylase	-	4.1.1.17
68374	ornithine decarboxylase	-	4.1.1.17	from API ID32E
68368	ornithine decarboxylase	-	4.1.1.17	from API 20E
121888	oxidase	-
68382	trypsin	-	3.4.21.4	from API zym
121888	tryptophan deaminase	-
68368	tryptophan deaminase	-	4.1.99.1	from API 20E
121888	urease	+	3.5.1.5
68374	urease	+	3.5.1.5	from API ID32E
68382	valine arylamidase	-		from API zym

API 20E

@ref	ONPG	ADH (Arg)	LDC (Lys)	ODC	CIT	H2S productionH2S	URE	TDA (Trp)	IND	Acetoin production (Voges Proskauer test)VP	GEL	GLU	MAN	INO	Sor	RHA	SAC	MEL	AMY	ARA	OX	Nitrite productionNO2	Reduction to N2N2	MotilityMOB	Growth on MacConkey mediumMAC	OF-O	OF-F
357	+	-	-	-	+	-	-	-	-	-	-	+	+	+	+	+	+	+	+	+	-	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.
357	+	-	+	-	+	-	+	-	-	-	-	+	+	+	+	+	+	+	+	+	-	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.
45338	+	-	+	-	-	-	+	-	-	+	-	+	+	+	+	+	+	+	+	+	-	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.
357	+	-	+	-	+	-	-	-	-	-	-	+	+	+	+	+	+	+	+	+	-	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.

API zym

@ref	Control	Alkaline phosphatase	Esterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	Lipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
121888	-	+	+	+	-	+	-	-	-	-	+	+	+	+	-	+	+	-	-	-

API ID32E

@ref	ODC	ADH (Arg)	LDC (Lys)	URE	LARL	GAT	5KG	LipaseLIP	Phenol red (Acidification)RP	beta GLU	MAN	MAL	ADO	PLE	beta GUR	MNT	IND	N-Acetyl-beta-Glucosaminidasebeta NAG	beta GAL	GLU	SAC	LARA	DARL	alpha GLU	alpha GAL	TRE	RHA	INO	CEL	SOR	alpha-MaltosidasealphaMAL	L-aspartic acid arylamidaseAspA
45338	-	-	+	+	-	+	-	-	-	+	+	+	+	+	-	-	-	-	+	+	+	+	+	-	+	+	+	+	+	+	-	-

API biotype100

@ref	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
121888	not determinedn.d.	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	-	-	+	-	+	+	+	-	-	+	+	+	+	-	+	+	+	+	-	-	+	+	+	+	+	+	-	-	+	-	+	-	-	-	+	-	+	-	-	-	+	+	-	+	+	+	-	+	-	+	+	+	+	+	+	+	-	-	-	-

Isolation, sampling and environmental information

Interaction and safety

Risk assessment

@ref	Biosafety level	Biosafety level comment
357	2	Risk group (German classification) According to TRBA 466
121888	2	Risk group (French classification) According to TRBA 466

Sequence information

Genome sequences

@ref	Description	Assembly level	INSDC accession	BV-BRC accession	NCBI tax ID	Score
66792	39304_F01 assembly for Klebsiella pneumoniae NCTC7427	contig	GCA_900451675	573.20129	573	78.27
124043	ASM5140087v1 assembly for Klebsiella pneumoniae ATCC 10031	scaffold	GCA_051400875		573	64.41

16S sequences

@ref	Description	Accession	Length	Database	NCBI tax ID
20218	Klebsiella pneumoniae strain ATCC 10031 16S ribosomal RNA gene, partial sequence	FJ971886	795		573

Genome-based predictions

Predictions

Predictions from Deep Learning for Genome Sequence Data. R package version 0.3.1 based on: Klebsiella pneumoniae NCTC7427
NCBI: GCA_900451675

@ref	Trait	Model	Prediction	Confidence in %	In training data
125439	spore_formation	BacteriaNetⓘ	no	91.10	no
125439	motility	BacteriaNetⓘ	yes	72.10	no
125439	gram_stain	BacteriaNetⓘ	negative	98.20	no
125439	oxygen_tolerance	BacteriaNetⓘ	aerobe	95.30	no

Predictions from bacterial phenotypic traits through improved machine learning using high-quality, curated datasets based on: Klebsiella pneumoniae strain NCTC7427
PATRIC: 573.20129

@ref	Trait	Model	Prediction	Confidence in %	In training data
125438	gram-positive	gram-positiveⓘ	no	99.50	no
125438	anaerobic	anaerobicⓘ	no	97.77	no
125438	spore-forming	spore-formingⓘ	no	89.95	no
125438	aerobic	aerobicⓘ	no	60.46	no
125438	thermophilic	thermophileⓘ	no	98.50	yes
125438	flagellated	motile2+ⓘ	no	78.34	no

Literature

Topic	Title	Authors	Journal	DOI	Year
	KpSC-ID: a multiplex real-time PCR assay for the simultaneous detection of the Klebsiella pneumoniae species complex and specific identification of Klebsiella pneumoniae, Klebsiella quasipneumoniae and Klebsiella variicola.	McAndrew G, Barbier E, Rodrigues C, Piveteau P, Brisse S, Reddington K.	Microbiology (Reading)	10.1099/mic.0.001587	2025
	Analysis of Bacterial Metabolites in Breath Gas of Critically Ill Patients for Diagnosis of Ventilator-Associated Pneumonia-A Proof of Concept Study.	Filipiak W, Wlodarski R, Zuchowska K, Tracewska A, Winiarek M, Daszkiewicz D, Marszalek M, Depka D, Bogiel T.	Biomolecules	10.3390/biom14121480	2024
	Saarvienin A-A Novel Glycopeptide with Potent Activity against Drug-Resistant Bacteria.	Kaur A, Guerrero-Garzon JF, Rasheed S, Zehl M, Fries F, Morgenstern B, Zotchev SB, Muller R.	Angew Chem Int Ed Engl	10.1002/anie.202425588	2025
Proteome	Proteome analysis, genetic characterization, and antibiotic resistance patterns of Klebsiella pneumoniae clinical isolates.	Marzouk E, Abalkhail A, ALqahtani J, Alsowat K, Alanazi M, Alzaben F, Alnasser A, Alasmari A, Rawway M, Draz A, Abu-Okail A, Altwijery A, Moussa I, Alsughayyir S, Alamri S, Althagafi M, Almaliki A, Elmanssury AE, Elbehiry A.	AMB Express	10.1186/s13568-024-01710-7	2024
	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Chembiochem	10.1002/cbic.202100609	2022
	Gold(III) Complexes with 2-(1-Ethylbenzyl)pyridine as Promising Antimicrobial and Antitumor Agents.	Zucca A, Canu B, Pilo MI, Stoccoro S, Senzacqua G, Fais S, Pichiri G, Scano A.	Molecules	10.3390/molecules30071611	2025
Pathogenicity	Ribosomal Target-Binding Sites of Antimicrobial Peptides Api137 and Onc112 Are Conserved among Pathogens Indicating New Lead Structures To Develop Novel Broad-Spectrum Antibiotics.	Kolano L, Knappe D, Volke D, Strater N, Hoffmann R.	Chembiochem	10.1002/cbic.202000109	2020
	A Human Lung-Associated Streptomyces sp. TR1341 Produces Various Secondary Metabolites Responsible for Virulence, Cytotoxicity and Modulation of Immune Response.	Herbrik A, Corretto E, Chronakova A, Langhansova H, Petraskova P, Hrdy J, Cihak M, Kristufek V, Bobek J, Petricek M, Petrickova K.	Front Microbiol	10.3389/fmicb.2019.03028	2019
Enzymology	Antimicrobial, antioxidant and anti-tyrosinase properties of extracts of the Mediterranean parasitic plant Cytinus hypocistis.	Zucca P, Pintus M, Manzo G, Nieddu M, Steri D, Rinaldi AC.	BMC Res Notes	10.1186/s13104-015-1546-5	2015
Pathogenicity	Antioxidant, Antimicrobial, and Other Biological Properties of Pompia Juice.	Barberis A, Deiana M, Spissu Y, Azara E, Fadda A, Serra PA, D'hallewin G, Pisano M, Serreli G, Orru G, Scano A, Steri D, Sanjust E.	Molecules	10.3390/molecules25143186	2020
	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	Bluhm ME, Schneider VA, Schafer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	Front Cell Dev Biol	10.3389/fcell.2016.00039	2016
Pathogenicity	Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens.	Berthold N, Czihal P, Fritsche S, Sauer U, Schiffer G, Knappe D, Alber G, Hoffmann R.	Antimicrob Agents Chemother	10.1128/aac.01923-12	2013
Enzymology	Large scale multiplex PCR improves pathogen detection by DNA microarrays.	Palka-Santini M, Cleven BE, Eichinger L, Kronke M, Krut O.	BMC Microbiol	10.1186/1471-2180-9-1	2009
Enzymology	Development of PCR primer systems for amplification of nitrite reductase genes (nirK and nirS) to detect denitrifying bacteria in environmental samples.	Braker G, Fesefeldt A, Witzel KP.	Appl Environ Microbiol	10.1128/aem.64.10.3769-3775.1998	1998
Enzymology	Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.	Spiess B, Buchheidt D, Baust C, Skladny H, Seifarth W, Zeilfelder U, Leib-Mosch C, Morz H, Hehlmann R.	J Clin Microbiol	10.1128/jcm.41.5.1811-1818.2003	2003
Enzymology	Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR.	Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mosch C, Hehlmann R.	J Clin Microbiol	10.1128/jcm.37.12.3865-3871.1999	1999
	Silver-coated Zea mays L. nanocatalyst for efficient Azo dye photodegradation and antimicrobial applications.	Abd El-Gawad WM, Elmaghraby K, El-Khawaga AM.	Sci Rep	10.1038/s41598-025-22961-9	2025
Enzymology	Phytochemical Composition, Biological Activities, and Mechanisms of Antibacterial Action of Selected Cameroonian Medicinal Plants.	Takongmo Matsuete G, Tangue Talom B, Tamokou JD.	Cureus	10.7759/cureus.86251	2025
	Liposomal Fluopsin C: Physicochemical Properties, Cytotoxicity, and Antibacterial Activity In Vitro and over In Vivo MDR Klebsiella pneumoniae Bacteremia Model.	Dealis Gomes ML, Afonso L, Basso KR, Alves LC, Macias EJN, Yamada-Ogatta SF, Guidi AC, de Mello JCP, Andrade FG, Cabeca LF, Cely MVT, Andrade G.	Antibiotics (Basel)	10.3390/antibiotics14090948	2025
	Ethanol Extract From the Stem Bark of Adansonia digitata L. (Baobab) Displays Therapeutic Potential Against Klebsiella pneumoniae Infection.	Matsuete GT, Tangue Talom B, Lacmata Tamekou S, Kenfack JO, Tamokou JD.	Cureus	10.7759/cureus.87520	2025
	Frog Skin Peptides Hylin-a1, AR-23, and RV-23: Promising Tools Against Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae Infections.	Chianese A, Ambrosino A, Giugliano R, Palma F, Parimal P, Acunzo M, Monti A, Doti N, Zannella C, Galdiero M, De Filippis A.	Antibiotics (Basel)	10.3390/antibiotics14040374	2025
Pathogenicity	Klebsiella pneumoniae derived outer membrane vesicles mediated bacterial virulence, antibiotic resistance, host immune responses and clinical applications.	Li L, Xu X, Cheng P, Yu Z, Li M, Yu Z, Cheng W, Zhang W, Sun H, Song X.	Virulence	10.1080/21505594.2025.2449722	2025
	Synthesis, characterization, and biomedical applications (antibacterial, antibiofilm, anticancer and effects on hospital-acquired pneumonia infection) of copper titanium oxide nanostructures.	Poudineh M, Valian M, Jassim AY, Ghorbani Z, Khaledi A, Salavati-Niasari M.	RSC Adv	10.1039/d4ra08476d	2025
	Synthesis and Antibacterial Evaluation of Chlorhexidine- and Triclosan-Impregnated Kaolinite Nanocomposites.	Alimbek A, Bekissanova Z, Otegenova B, Jumagaziyeva A, Zhaksybay BB, Zhumadilova Y, Ospanova A.	Materials (Basel)	10.3390/ma18010174	2025
	The transcriptional regulator Fur modulates the expression of uge, a gene essential for the core lipopolysaccharide biosynthesis in Klebsiella pneumoniae.	Muner JJ, de Oliveira PAA, Baboghlian J, Moura SC, de Andrade AG, de Oliveira MM, Campos YF, Mancano ASF, Siqueira NMG, Pacheco T, Ferraz LFC.	BMC Microbiol	10.1186/s12866-024-03418-x	2024
Pathogenicity	Klebsiella pneumoniae-OMVs activate death-signaling pathways in Human Bronchial Epithelial Host Cells (BEAS-2B).	Dell'Annunziata F, Ciaglia E, Folliero V, Lopardo V, Maciag A, Galdiero M, Puca AA, Franci G.	Heliyon	10.1016/j.heliyon.2024.e29017	2024
	Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance.	Blanco-Martin T, Gonzalez-Pinto L, Aja-Macaya P, Rodriguez-Pallares S, Sanchez-Pena L, Gato E, Fernandez-Lopez MdC, Outeda-Garcia M, Rodriguez-Coello A, Pedraza-Merino R, Alonso-Garcia I, Vazquez-Ucha JC, Martinez-Martinez L, Arca-Suarez J, Beceiro A, Bou G.	Antimicrob Agents Chemother	10.1128/aac.01120-24	2024
	Protection Against Pneumonia Induced by Vaccination with Fimbriae Subunits from Klebsiella pneumoniae.	Assoni L, Ciaparin I, Trentini MM, Baboghlian J, Rodrigo G, Ferreira BV, Pereira JA, Martinez C, Ferraz L, Girardello R, Carvalho LM, Hakansson AP, Converso TR, Darrieux M.	Vaccines (Basel)	10.3390/vaccines13030303	2025
	The inhibitory potential of three scorpion venom peptides against multidrug-resistant Klebsiella pnemoniae.	Giugliano R, Della Marca R, Chianese A, Monti A, Donadio F, Esposito E, Doti N, Zannella C, Galdiero M, De Filippis A.	Front Microbiol	10.3389/fmicb.2025.1569719	2025
	Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract.	Sotirova Y, Ivanova N, Ermenlieva N, Vilhelmova-Ilieva N, Simeonova L, Metodiev M, Gugleva V, Andonova V.	Pharmaceuticals (Basel)	10.3390/ph18030366	2025
	Coumarin/nitrogen-bearing heterocyclic hybrid-loaded electrospun PMMA/PVP nanofibrous scaffolds for accelerating topical wound healing rates: synthesis and in vitro bio-evaluation.	Salim SA, Ali MAM, Abed T, Chaudhary AA, Boufahja F, Hasanein AM, Abdelaziz E, El-Moslamy SH, Negm A, El Sayed IET, Kamoun EA, Hawata MA.	RSC Adv	10.1039/d5ra02535d	2025
	Outer Membrane Vesicles Transmitting bla_NDM-1 Mediate the Emergence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae.	Tang B, Yang A, Liu P, Wang Z, Jian Z, Chen X, Yan Q, Liang X, Liu W.	Antimicrob Agents Chemother	10.1128/aac.01444-22	2023
	Detection of antimicrobial impact on gram-negative bacterial cell envelope based on single-cell imaging by scanning electron microscopy.	Hisada A, Matsumoto E, Hirano R, Konomi M, Bou Khalil JY, Raoult D, Ominami Y.	Sci Rep	10.1038/s41598-023-38198-3	2023
	Latest Update on Outer Membrane Vesicles and Their Role in Horizontal Gene Transfer: A Mini-Review.	Marinacci B, Krzyzek P, Pellegrini B, Turacchio G, Grande R.	Membranes (Basel)	10.3390/membranes13110860	2023
	ZnO Nanoparticles Enhance the Antimicrobial Properties of Two-Sided-Coated Cotton Textile.	Giedraitiene A, Ruzauskas M, Siugzdiniene R, Tuckute S, Grigonis K, Milcius D.	Nanomaterials (Basel)	10.3390/nano14151264	2024
	Extracellular host DNA contributes to pathogenic biofilm formation during periodontitis.	Slobodianyk-Kolomoiets M, Khlebas S, Mazur I, Rudnieva K, Potochilova V, Iungin O, Kamyshnyi O, Kamyshna I, Potters G, Spiers AJ, Moshynets O.	Front Cell Infect Microbiol	10.3389/fcimb.2024.1374817	2024
	Titanium dioxide nanoparticles augment Ciprofloxacin activity via Inhibition of biofilm formation for multidrug resistance bacteria in-vitro and insilco prediction study.	Najm MAA, Shakir HA, Hasen ST, Jawad KH, Hasoon BA, Jabir MS, Issa AA, Albukhaty S, Gatasheh MK, Molla MH.	Sci Rep	10.1038/s41598-025-93569-2	2025
	Probiotic potential of enterococcus lactis in improving egg production and quality in quails during late egg-laying period.	Liu L, Liu C, Wang H, Tang H, Chen Z, Dou X, Chang J, Li Z, Wang Z, Mei Y, Ren M.	Poult Sci	10.1016/j.psj.2025.104765	2025
	Novel Triazole-Carbohydrazide hydrazones with dual antioxidant and antibacterial potential.	Badawy SA, Rewish NM, Fadda AA, Elmorsy MR.	Sci Rep	10.1038/s41598-025-26016-x	2025
	Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of beta-lactams and the novel beta-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing Enterobacterales.	Blanco-Martin T, Lopez-Hernandez I, Aracil B, Gonzalez-Pinto L, Aja-Macaya P, Alonso-Garcia I, Rodriguez-Pallares S, Sanchez-Pena L, Outeda-Garcia M, Perez-Vazquez M, Vazquez-Ucha JC, Beceiro A, Pascual A, Bou G, Lopez-Cerero L, Oteo-Iglesias J, Arca-Suarez J, GEMARA-SEIMC/CIBERINFEC Study Group on the activity and resistance mechanisms to new b-lactams and b-lactamase inhibitors (PROTECT).	Antimicrob Agents Chemother	10.1128/aac.00924-24	2024
	Effect of Mentha longifolia essential oil on oqxA efflux pump gene expression and biofilm formation in ciprofloxacin-resistant Klebsiella pneumoniae strains.	Keyhani S, Alikhani MY, Doosti-Irani A, Shokoohizadeh L.	Iran J Microbiol	10.18502/ijm.v16i4.16315	2024
Genetics	Antibacterial activity and genomic characterisation of a novel Brevibacillus laterosporus XJ-24-3 isolated from Xinjiang, China.	Wu M, Chen S, Li G, Zhang H, Duan F, Zuo Y, Cai X, Li J, Meng Q, Qiao J.	J Vet Res	10.2478/jvetres-2025-0039	2025
	Mohangic Acid H and Mohangiol: New p-Aminoacetophenone Derivatives from a Mudflat-Derived Streptomyces sp.	Son J, Lee JH, Cho YJ, Moon K, Bae M.	Mar Drugs	10.3390/md23080307	2025
	Regulatory effects on virulence and phage susceptibility revealed by sdiA mutation in Klebsiella pneumoniae.	Silva-Bea S, Maseda P, Otero A, Romero M.	Front Cell Infect Microbiol	10.3389/fcimb.2025.1562402	2025
	Synthesis and Antimicrobial Activity of 3D Micro-Nanostructured Diatom Biosilica Coated by Epitaxially Growing Ag-AgCl Hybrid Nanoparticles.	Bekissanova Z, Railean V, Wojtczak I, Brzozowska W, Trykowski G, Ospanova A, Sprynskyy M.	Biomimetics (Basel)	10.3390/biomimetics9010005	2023
	Animal models of Klebsiella pneumoniae mucosal infections.	Assoni L, Couto AJM, Vieira B, Milani B, Lima AS, Converso TR, Darrieux M.	Front Microbiol	10.3389/fmicb.2024.1367422	2024
	Reducing the effective dose of doxycycline using chitosan silver nanocomposite as a carriers on gram positive and gram-negative bacteria.	Mostafa EM, Badr Y, Hashem MM, Abo-El-Sooud K, Faid AH.	Sci Rep	10.1038/s41598-024-78326-1	2024
	Phage-antibiotic synergy to combat multidrug resistant strains of Gram-negative ESKAPE pathogens.	Morris TC, Reyneke B, Khan S, Khan W.	Sci Rep	10.1038/s41598-025-01489-y	2025
	Influence of Lavender Essential Oil on the Physical and Antibacterial Properties of Chitosan Sponge for Hemostatic Applications.	Gheorghita D, Antoniac I, Moldovan H, Antoniac A, Grosu E, Motelica L, Ficai A, Oprea O, Vasile E, Ditu LM, Raiciu AD.	Int J Mol Sci	10.3390/ijms242216312	2023
	Discovery and Heterologous Expression of Trilenodin, an Antimicrobial Lasso Peptide with a Unique Tri-Isoleucine Motif.	Pulliam C, Xue D, Campbell A, Older E, Li J.	Chembiochem	10.1002/cbic.202400586	2024
Genetics	In silico genome-scale metabolic modeling and in vitro static time-kill studies of exogenous metabolites alone and with polymyxin B against Klebsiella pneumoniae.	Chung WY, Abdul Rahim N, Mahamad Maifiah MH, Hawala Shivashekaregowda NK, Zhu Y, Wong EH.	Front Pharmacol	10.3389/fphar.2022.880352	2022
	Strontium/copper doped nano-bioactive glass for biomedical applications.	Ahmed MM, El-Kheshen AA, Moaness M.	Sci Rep	10.1038/s41598-025-27551-3	2025
	Exploring the antimicrobial potential of Rosmarinus officinalis against urinary tract infection isolates in Amman, Jordan	Husein N, Laban N, Owais D.	Iran J Microbiol		2025
	Exploring the principles behind antibiotics with limited resistance.	Maharramov E, Czikkely MS, Szili P, Farkas Z, Grezal G, Daruka L, Kurko E, Meszaros L, Daraba A, Kovacs T, Bognar B, Juhasz S, Papp B, Lazar V, Pal C.	Nat Commun	10.1038/s41467-025-56934-3	2025
	The effects of sequencing strategies on Metagenomic pathogen detection using bronchoalveolar lavage fluid samples.	Li Z, Guo Z, Wu W, Tan L, Long Q, Xia H, Hu M.	Heliyon	10.1016/j.heliyon.2024.e33429	2024
	New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity.	Cotman AE, Fulgheri F, Piga M, Persolja P, Tiz DB, Skok Z, Durcik M, Sterle M, Dernovsek J, Cruz CD, Tammela P, Szili PE, Daruka L, Pal C, Zega A, Masic LP, Ilas J, Tomasic T, Kikelj D, Zidar N.	RSC Adv	10.1039/d4ra04802d	2024
Pathogenicity	Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae.	Bleriot I, Blasco L, Pacios O, Fernandez-Garcia L, Lopez M, Ortiz-Cartagena C, Barrio-Pujante A, Fernandez-Cuenca F, Pascual A, Martinez-Martinez L, Oteo-Iglesias J, Tomas M.	Microbiol Spectr	10.1128/spectrum.03974-22	2023
	Essential Oils Obtained from Sicilian Citrus reticulata Blanco By-Products: Antibacterial and Allelopathic Activity.	Geraci A, Postiglione A, Sgadari F, Schicchi R, Badalamenti N, Bruno M, Basile A, Dentato M, Maresca V.	Plants (Basel)	10.3390/plants13243527	2024
	Phytochemical components and antibacterial activity of two populations of Senecio vulgaris L. essential oils as traditional medicine plant	Hajmoradi F, Fathi H, Moghadami F.	Iran J Microbiol		2025
	Development of Antibacterial Cotton Textiles by Deposition of Fe₂O₃ Nanoparticles Using Low-Temperature Plasma Sputtering.	Giedraitiene A, Ruzauskas M, Siugzdiniene R, Tuckute S, Grigonis K, Milcius D.	Nanomaterials (Basel)	10.3390/nano13243106	2023
	Extracellular Vesicles from a Biofilm of a Clinical Isolate of Candida albicans Negatively Impact on Klebsiella pneumoniae Adherence and Biofilm Formation.	Imparato M, Maione A, Buonanno A, Gesuele R, Gallucci N, Corsaro MM, Paduano L, Casillo A, Guida M, Galdiero E, de Alteriis E.	Antibiotics (Basel)	10.3390/antibiotics13010080	2024
	Evaluation of 2,6-difluoro-3-(oxazol-2-ylmethoxy)benzamide chemotypes as Gram-negative FtsZ inhibitors.	Rosado-Lugo JD, Sun Y, Banerjee A, Cao Y, Datta P, Zhang Y, Yuan Y, Parhi AK.	J Antibiot (Tokyo)	10.1038/s41429-022-00531-9	2022
	Phage Therapy for Hospital-Acquired Respiratory Bacterial Infections: A Review Fagoterapia para infecciones respiratorias bacterianas de adquisición nosocomial: revisión de la literatura	Munoz-Egea M, Rodriguez A, Esteban J, Garcia-Quintanilla M.	Open Respir Arch		2025
	Evaluation of the mechanistic basis for the antibacterial activity of ursolic acid against Staphylococcus aureus.	Liu G, Qin P, Cheng X, Wu L, Zhao W, Gao W.	Front Microbiol	10.3389/fmicb.2024.1389242	2024
	Spices as Sustainable Food Preservatives: A Comprehensive Review of Their Antimicrobial Potential.	Sulieman AME, Abdallah EM, Alanazi NA, Ed-Dra A, Jamal A, Idriss H, Alshammari AS, Shommo SAM.	Pharmaceuticals (Basel)	10.3390/ph16101451	2023
	From Obscurity to Opportunity: LpxH Emerges as a Promising Antibiotic Target in the Battle against Gram-Negative Pathogens.	Dome PA, Cochrane CS, Switzer HJ, Lee H, Jeong P, Hong J, Zhou P.	ACS Infect Dis	10.1021/acsinfecdis.5c00625	2025
	Hydrogel Containing Biogenic Silver Nanoparticles and Origanum vulgare Essential Oil for Burn Wounds: Antimicrobial Efficacy Using Ex Vivo and In Vivo Methods Against Multidrug-Resistant Microorganisms.	Kimura AH, Dahmer D, Isawa LA, da Silva ABO, Souza LMDS, Takata PH, Scandorieiro S, Deonas AN, Germiniani-Cardozo J, Vespero EC, Perugini MRE, Lincopan N, Garcia Lonni AAS, Nakazato G, Kobayashi RKT.	Pharmaceutics	10.3390/pharmaceutics17040503	2025
	Controlling drug-resistant bacteria in Arabian horses: bacteriophage cocktails for treating wound infections.	Khalid E, Tartor YH, Ammar AM, Abdelaziz R, Mahmmod Y, Abdelkhalek A.	Front Vet Sci	10.3389/fvets.2025.1609955	2025
	Pyrolized Diatomaceous Biomass Doped with Epitaxially Growing Hybrid Ag/TiO₂ Nanoparticles: Synthesis, Characterisation and Antibacterial Application.	Brzozowska W, Wojtczak I, Railean V, Bekissanova Z, Trykowski G, Buszewski B, Sprynskyy M.	Materials (Basel)	10.3390/ma16124345	2023
	ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro.	Daruka L, Czikkely MS, Szili P, Farkas Z, Balogh D, Grezal G, Maharramov E, Vu TH, Sipos L, Juhasz S, Dunai A, Daraba A, Szamel M, Sari T, Stirling T, Vasarhelyi BM, Ari E, Christodoulou C, Manczinger M, Enyedi MZ, Jaksa G, Kovacs K, van Houte S, Pursey E, Pinter L, Haracska L, Kintses B, Papp B, Pal C.	Nat Microbiol	10.1038/s41564-024-01891-8	2025
	Biological Activities of Leonotis ocymifolia (Burm.f.) and Its Antibacterial Activities Against ESKAPE Pathogens.	Matlou TD, Matotoka MM, Mnisi TJ, Masoko P.	Antibiotics (Basel)	10.3390/antibiotics14030238	2025
	Outer Membrane Vesicles Derived from Klebsiella pneumoniae Influence the miRNA Expression Profile in Human Bronchial Epithelial BEAS-2B Cells.	Dell'Annunziata F, Ilisso CP, Dell'Aversana C, Greco G, Coppola A, Martora F, Dal Piaz F, Donadio G, Falanga A, Galdiero M, Altucci L, Galdiero M, Porcelli M, Folliero V, Franci G.	Microorganisms	10.3390/microorganisms8121985	2020
	Analysis of Eremostachys hyoscyamoides essential oil composition and assessing the antibacterial and antioxidant properties of the ethanol extract.	Talebi M, Oskouie AA, Mahboubi A, Khani M, Mojab F.	Heliyon	10.1016/j.heliyon.2024.e38389	2024
	In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol.	Kriz R, Spettel K, Pichler A, Schefberger K, Sanz-Codina M, Lotsch F, Harrison N, Willinger B, Zeitlinger M, Burgmann H, Lagler H.	J Antibiot (Tokyo)	10.1038/s41429-024-00762-y	2024
	Exploring the antimicrobial activity of fermented and non-fermented cocoa bean shell extracts through metabolomics analysis and synergistic studies.	Chong YK, Gan WK, Tan JBL, Mohd Jaaffar AKH, Baharum Z, Yeong KY.	J Sci Food Agric	10.1002/jsfa.14366	2025
	Gut microbiota facilitate chronic spontaneous urticaria.	Zhu L, Jian X, Zhou B, Liu R, Munoz M, Sun W, Xie L, Chen X, Peng C, Maurer M, Li J.	Nat Commun	10.1038/s41467-023-44373-x	2024
Phylogeny	Isolation and Characterization of Galloylglucoses Effective against Multidrug-Resistant Strains of Escherichia coli and Klebsiella pneumoniae.	Masota NE, Ohlsen K, Schollmayer C, Meinel L, Holzgrabe U.	Molecules	10.3390/molecules27155045	2022
Metabolism	The role of RND-type efflux pumps in multidrug-resistant mutants of Klebsiella pneumoniae.	Ni RT, Onishi M, Mizusawa M, Kitagawa R, Kishino T, Matsubara F, Tsuchiya T, Kuroda T, Ogawa W.	Sci Rep	10.1038/s41598-020-67820-x	2020
	Green synthesis of trimetallic CuO/Ag/ZnO nanocomposite using Ziziphus spina-christi plant extract: characterization, statistically experimental designs, and antimicrobial assessment.	El-Sawaf AK, El-Moslamy SH, Kamoun EA, Hossain K.	Sci Rep	10.1038/s41598-024-67579-5	2024
Genetics	Unveiling a New Antimicrobial Peptide with Efficacy against P. aeruginosa and K. pneumoniae from Mangrove-Derived Paenibacillus thiaminolyticus NNS5-6 and Genomic Analysis.	Sermkaew N, Atipairin A, Krobthong S, Aonbangkhen C, Yingchutrakul Y, Uchiyama J, Songnaka N.	Antibiotics (Basel)	10.3390/antibiotics13090846	2024
Pathogenicity	Antibacterial Activity of Defatted and Nondefatted Methanolic Extracts of Aframomum melegueta K. Schum. against Multidrug-Resistant Bacteria of Clinical Importance.	Olajuyigbe OO, Adedayo O, Coopoosamy RM.	ScientificWorldJournal	10.1155/2020/4808432	2020
	Complete Genome Sequences of Five Bacteriophages That Infect Enterobacteriales Hosts.	Evans S, Cobbley H, Davis K, Divis T, Eberhard N, Flor S, Harris EB, Gordon JB, Hyer M, Larson W, Suorsa AR, Sharma R, Sork C, Thompson DW, Wells L, Casjens SR, Grose JH.	Microbiol Resour Announc	10.1128/mra.01223-21	2022
	PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens.	Euler CW, Raz A, Hernandez A, Serrano A, Xu S, Andersson M, Zou G, Zhang Y, Fischetti VA, Li J.	Antimicrob Agents Chemother	10.1128/aac.01519-22	2023
	Rapid Detection of Piperacillin-Tazobactam Resistance in Klebsiella pneumoniae and Escherichia coli.	Ortiz de la Rosa JM, Rodriguez-Villodres A, Gimeno Gascon MA, Martin-Gutierrez G, Cisneros JM, Lepe JA.	Microbiol Spectr	10.1128/spectrum.04366-22	2023
	Enhancing lower respiratory tract infection diagnosis: implementation and clinical assessment of multiplex PCR-based and hybrid capture-based targeted next-generation sequencing.	Yin Y, Zhu P, Guo Y, Li Y, Chen H, Liu J, Sun L, Ma S, Hu C, Wang H.	EBioMedicine	10.1016/j.ebiom.2024.105307	2024
Pathogenicity	Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations.	Szili P, Draskovits G, Revesz T, Bogar F, Balogh D, Martinek T, Daruka L, Spohn R, Vasarhelyi BM, Czikkely M, Kintses B, Grezal G, Ferenc G, Pal C, Nyerges A.	Antimicrob Agents Chemother	10.1128/aac.00207-19	2019
Genetics	Efficacy of colistin-based combinations against pandrug-resistant whole-genome-sequenced Klebsiella pneumoniae isolated from hospitalized patients in Egypt: an in vitro/vivo comparative study.	Attalla ET, Khalil AM, Zakaria AS, Evans R, Tolba NS, Mohamed NM.	Gut Pathog	10.1186/s13099-024-00667-z	2024
	In Situ Gelling Behavior and Biopharmaceutical Characterization of Nano-Silver-Loaded Poloxamer Matrices Designed for Nasal Drug Delivery.	Ivanova N, Ermenlieva N, Simeonova L, Vilhelmova-Ilieva N, Bratoeva K, Stoyanov G, Andonova V.	Gels	10.3390/gels10060385	2024
	Systematically attenuating DNA targeting enables CRISPR-driven editing in bacteria.	Collias D, Vialetto E, Yu J, Co K, Almasi EDH, Ruttiger AS, Achmedov T, Strowig T, Beisel CL.	Nat Commun	10.1038/s41467-023-36283-9	2023
Genetics	Antibacterial activity of metal-phenanthroline complexes against multidrug-resistant Irish clinical isolates: a whole genome sequencing approach.	O'Shaughnessy M, Hurley J, Dillon SC, Herra C, McCarron P, McCann M, Devereux M, Howe O.	J Biol Inorg Chem	10.1007/s00775-022-01979-8	2023
	Reproducibility challenges in the search for antibacterial compounds from nature.	Masota NE, Vogg G, Ohlsen K, Holzgrabe U.	PLoS One	10.1371/journal.pone.0255437	2021
	A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens.	Bryan EJ, Qiao Q, Wang Y, Roberge JY, LaVoie EJ, Pilch DS.	Antibiotics (Basel)	10.3390/antibiotics13030209	2024
	Span 60/Cholesterol Niosomal Formulation as a Suitable Vehicle for Gallic Acid Delivery with Potent In Vitro Antibacterial, Antimelanoma, and Anti-Tyrosinase Activity.	Zolghadri S, Asad AG, Farzi F, Ghajarzadeh F, Habibi Z, Rahban M, Zolghadri S, Stanek A.	Pharmaceuticals (Basel)	10.3390/ph16121680	2023
	Antibacterial and anticancer properties of Solanum mauritianum fruit components analyzed using LC-QTOF-MS/MS.	Ogofure AG, Sebola T, Green E.	Sci Rep	10.1038/s41598-025-01348-w	2025
	Colorimetric pH-sensitive hydrogel film based on kappa-carrageenan containing quercetin or eucalyptus leaf extract for freshness monitoring of chicken meat.	Mirzaei A, Bina Jorshari Y, Jananshir S, Noori M, Mahdavi M.	Food Chem X	10.1016/j.fochx.2024.101307	2024
	Genome Sequences of 22 T1-like Bacteriophages That Infect Enterobacteriales.	Cranston A, Danielson P, Arens DK, Barker A, Birch EK, Brown H, Carr E, Cero P, Chow J, Correa E, Dean J, Dunn M, Eberhard N, Egbert A, Foster K, Gaertner R, Gleave A, Gomez A, Gordon JB, Harris EB, Heaps C, Hyer M, Johnson A, Johnson L, Kim M, Kruger JL, Leonard T, LeSueur A, Lima S, Marshall N, Moulton R, Newey CR, Owen D, Packard A, Rolfson A, Suorsa AR, Rodriguez W, Sandoval C, Sharma R, Smith A, Sork C, Soule C, Soule S, Stewart J, Stoker T, Thompson DW, Thurgood T, Walker J, Zaugg E, Casjens SR, Grose JH.	Microbiol Resour Announc	10.1128/mra.01221-21	2022
	Killing efficacy of a new hypothermic corneal storage medium against the micro-organisms frequently found in human donor cornea intended for transplantation.	Giurgola L, Gatto C, Honisch C, Rossi O, Ragazzi E, D'Amato Tothova J.	BMJ Open Ophthalmol	10.1136/bmjophth-2021-000833	2021
	Pistacia vera L. as natural source against antimicrobial and antiviral resistance.	Mandalari G, Pennisi R, Gervasi T, Sciortino MT.	Front Microbiol	10.3389/fmicb.2024.1396514	2024
	Towards Safe and Effective Biomedical Nanocoatings: Plasma-Sputtered Magnesium-Based Nanoparticles with Cytoprotective, Antimicrobial and Antialgal Properties.	Rodaite R, Kairyte L, Giedraitiene A, Ruzauskas M, Siugzdiniene R, Ciapiene I, Tatarunas V, Varnagiris S, Milcius D.	Molecules	10.3390/molecules30173526	2025
	Antibacterial and Antimycotic Activity of Epilobium angustifolium L. Extracts: A Review.	Dreger M, Adamczak A, Foksowicz-Flaczyk J.	Pharmaceuticals (Basel)	10.3390/ph16101419	2023
	Qualitative Profiling, Antioxidant and Antimicrobial Activities of Polar and Nonpolar Basil Extracts.	Vidakovic V, Vujic B, Jadranin M, Novakovic I, Trifunovic S, Tesevic V, Mandic B.	Foods	10.3390/foods13182993	2024
	Identification of novel small-molecular inhibitors of Staphylococcus aureus sortase A using hybrid virtual screening.	Volynets GP, Barthels F, Hammerschmidt SJ, Moshynets OV, Lukashov SS, Starosyla SA, Vyshniakova HV, Iungin OS, Bdzhola VG, Prykhod'ko AO, Syniugin AR, Sapelkin VM, Yarmoluk SM, Schirmeister T.	J Antibiot (Tokyo)	10.1038/s41429-022-00524-8	2022
	Development of a Multiplex Polymerase Chain Reaction-Based DNA Lateral Flow Assay as a Point-of-Care Diagnostic for Fast and Simultaneous Detection of MRSA and Vancomycin Resistance in Bacteremia.	Kashef MT, Helmy OM.	Diagnostics (Basel)	10.3390/diagnostics12112691	2022
	Improving stability of frying oils and food quality with addition of dried olive mill wastewater.	Jeba RH, Hemada HM, Nadir AA, Mansour ME.	NPJ Sci Food	10.1038/s41538-025-00430-x	2025
	Nanoemulsion and nanoencapsulation of a hydroethanolic extract of Nettle (Urtica dioica) and Wormwood (Artemisia absinthium): comparison of antibacterial and anticancer activity.	Rahmani Z, Karimi M, Saffari I, Mirzaei H, Nejati M, Sharafati Chaleshtori R.	Front Chem	10.3389/fchem.2024.1266573	2024
	Efficacious antibacterial potency of novel bacteriophages against ESBL-producing Klebsiella pneumoniae isolated from burn wound infections.	Torabi LR, Naghavi NS, Doudi M, Monajemi R.	Iran J Microbiol	10.18502/ijm.v13i5.7435	2021
	Anti-Microbial Activities of Mussel-Derived Recombinant Proteins against Gram-Negative Bacteria.	Kim DY, Oh YB, Park JS, Min YH, Park MC.	Antibiotics (Basel)	10.3390/antibiotics13030239	2024
	SdiA, a Quorum-Sensing Regulator, Suppresses Fimbriae Expression, Biofilm Formation, and Quorum-Sensing Signaling Molecules Production in Klebsiella pneumoniae.	Pacheco T, Gomes AEI, Siqueira NMG, Assoni L, Darrieux M, Venter H, Ferraz LFC.	Front Microbiol	10.3389/fmicb.2021.597735	2021
	Fractionation of Carlina acaulis L. Root Methanolic Extract as a Promising Path towards New Formulations against Bacillus cereus and Methicillin-Resistant Staphylococcus aureus.	Wnorowska S, Grzegorczyk A, Kurzepa J, Maggi F, Strzemski M.	Molecules	10.3390/molecules29091939	2024
	Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.	Kim SJ, Jo J, Kim J, Ko KS, Lee W.	Microbiol Spectr	10.1128/spectrum.03687-23	2024
	Electrochemical and DFT insights into 2-amino-4-(4-hydroxy-3-methoxyphenyl)-7-methyl-4H-chromene-3-carbonitrile: an innovative strategy for antibacterial activity and corrosion protection of carbon steel.	Al Jahdaly BA.	RSC Adv	10.1039/d4ra03785e	2024
	The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae.	Gholizadeh O, Ghaleh HEG, Tat M, Ranjbar R, Dorostkar R.	Virol J	10.1186/s12985-024-02450-7	2024
	Interaction of Ziziphus mucronata subsp. mucronata Methanol Extract and First-Line Antibiotics is Synergistic In Vitro through Production of Reactive Oxygen Species.	Olajuyigbe AA, Olajuyigbe OO, Coopoosamy RM.	J Trop Med	10.1155/2020/4087394	2020
	Antibacterial and Antifungal Properties of New Synthetic Tricyclic Flavonoids.	Sarbu LG, Rosca I, Birsa ML.	Antibiotics (Basel)	10.3390/antibiotics14030307	2025
	Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model.	Abbott IJ, van Gorp E, Cottingham H, Macesic N, Wallis SC, Roberts JA, Meletiadis J, Peleg AY.	J Antimicrob Chemother	10.1093/jac/dkac402	2023
Genetics	Genome-guided purification and characterization of polymyxin A1 from Paenibacillus thiaminolyticus SY20: A rarely explored member of polymyxins.	Wu YP, Liu DM, Liang MH, Huang YY, Lin J, Xiao LF.	Front Microbiol	10.3389/fmicb.2022.962507	2022
Genetics	Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.	Mohammadi M, Saffari M, Siadat SD, Hejazi SH, Shayestehpour M, Motallebi M, Eidi M.	Ann Clin Microbiol Antimicrob	10.1186/s12941-023-00567-1	2023
	Successful Removal of Clostridioides Difficile Spores and Pathogenic Bacteria From a Launderable Barrier Using a Commercial Laundry Process.	Hooker EA, Ulrich D, Brooks D.	Infect Dis (Auckl)	10.1177/1178633720923657	2020
	Identification of Potent Bioassay Guided Terpenoid and Glycoside Root Fractions of Astragalus candolleanus against Clinically Significant Bacterial Strains.	Nagarajan K, Ghai R, Varshney G, Grover P, Genovese C, D'Angeli F, Goel R, Prasad T, Kalaivani M, Teotia AK.	Int J Microbiol	10.1155/2022/4584799	2022
	Therapeutic Potential of Punica granatum and Isolated Compounds: Evidence-Based Advances to Treat Bacterial Infections.	Mendes PM, Gomes Fontoura GM, Rodrigues LDS, Souza AS, Viana JPM, Fernandes Pereira AL, Dutra RP, Nogueira Ferreira AG, Neto MS, Reis AS, Berretta AA, Monteiro-Neto V, Maciel MCG.	Int J Microbiol	10.1155/2023/4026440	2023
Biotechnology	Iron oxide/silver-doped iron oxide nanoparticles: facile synthesis, characterization, antibacterial activity, genotoxicity and anticancer evaluation	Abdelghany S, Elsayed A, Kabary H, Salaheldin H.	Sci Rep		2025
Enzymology	Evaluation of Metallo-beta-Lactamase Susceptibility Testing in a Physiologic Medium.	Asempa TE, Bajor H, Mullins JH, Hartnett J, Nicolau DP.	Microbiol Spectr	10.1128/spectrum.01670-21	2021
	Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis.	Li H, Kang WT, Zheng Y, He Y, Zhong R, Fang S, Wen W, Liu S, Lin S.	Sci Adv	10.1126/sciadv.adt4723	2025
	Hydantoin derivative dimers as broad-spectrum antimicrobial agents against ESKAPE pathogens with enhanced killing rate and stability.	Chen Y, Jiang H, Sun Z, Liu F, Su M.	RSC Med Chem	10.1039/d4md00374h	2024
	Thymol and carvacrol against Klebsiella: anti-bacterial, anti-biofilm, and synergistic activities-a systematic review.	Farhadi K, Rajabi E, Varpaei HA, Iranzadasl M, Khodaparast S, Salehi M.	Front Pharmacol	10.3389/fphar.2024.1487083	2024
	Antimicrobial betalains.	Wijesinghe VN, Choo WS.	J Appl Microbiol	10.1111/jam.15798	2022
	From Burst to Sustained Release: The Effect of Antibiotic Structure Incorporated into Chitosan-Based Films.	Sczesny NF, Wiggers HJ, Bueno CZ, Chevallier P, Copes F, Mantovani D.	Antibiotics (Basel)	10.3390/antibiotics13111055	2024
	Proteinase K-pretreated ConA-based ELISA assay: a novel urine LAM detection strategy for TB diagnosis.	Huang H, Qu R, Wu K, Xu J, Li J, Lu S, Sui G, Fan XY.	Front Microbiol	10.3389/fmicb.2023.1236599	2023
	Repurposing 9-Aminoacridine as an Adjuvant Enhances the Antimicrobial Effects of Rifampin against Multidrug-Resistant Klebsiella pneumoniae.	She P, Li Y, Li Z, Liu S, Yang Y, Li L, Zhou L, Wu Y.	Microbiol Spectr	10.1128/spectrum.04474-22	2023
	Essential Oil from Croton blanchetianus Leaves: Anticandidal Potential and Mechanisms of Action.	Malveira EA, Souza PFN, Neto NAS, Aguiar TKB, Rodrigues NS, Henrique CWB, Silva AFB, Lima LB, Albuquerque CC, Freitas CDT.	J Fungi (Basel)	10.3390/jof8111147	2022
	Fluopsin C for Treating Multidrug-Resistant Infections: In vitro Activity Against Clinically Important Strains and in vivo Efficacy Against Carbapenemase-Producing Klebsiella pneumoniae.	Navarro MOP, Simionato AS, Perez JCB, Barazetti AR, Emiliano J, Niekawa ETG, Andreata MFL, Modolon F, Dealis ML, Araujo EJA, Carlos TM, Scarpelim OJ, da Silva DB, Chryssafidis AL, Bruheim P, Andrade G.	Front Microbiol	10.3389/fmicb.2019.02431	2019
	Resistance Modulation Action, Time-Kill Kinetics Assay, and Inhibition of Biofilm Formation Effects of Plumbagin from Plumbago zeylanica Linn.	Adusei EBA, Adosraku RK, Oppong-Kyekyeku J, Amengor CDK, Jibira Y.	J Trop Med	10.1155/2019/1250645	2019
	Eco friendly silver nanoparticles synthesis by Brassica oleracea and its antibacterial, anticancer and antioxidant properties.	Ansar S, Tabassum H, Aladwan NSM, Naiman Ali M, Almaarik B, AlMahrouqi S, Abudawood M, Banu N, Alsubki R.	Sci Rep	10.1038/s41598-020-74371-8	2020
	Horizontal gene transfer via OMVs co-carrying virulence and antimicrobial-resistant genes is a novel way for the dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae.	Li P, Luo W, Xiang TX, Jiang Y, Liu P, Wei DD, Fan L, Huang S, Liao W, Liu Y, Zhang W.	Front Microbiol	10.3389/fmicb.2022.945972	2022
	The Membranotropic Peptide gH625 to Combat Mixed Candida albicans/Klebsiella pneumoniae Biofilm: Correlation between In Vitro Anti-Biofilm Activity and In Vivo Antimicrobial Protection.	Maione A, de Alteriis E, Carraturo F, Galdiero S, Falanga A, Guida M, Di Cosmo A, Maselli V, Galdiero E.	J Fungi (Basel)	10.3390/jof7010026	2021
	Ethnobotany, Phytochemistry, and Biological Activity of Extracts and Non-Volatile Compounds from Lantana camara L. and Semisynthetic Derivatives-An Updated Review.	Ramirez J, Armijos C, Espinosa-Ortega N, Castillo LN, Vidari G.	Molecules	10.3390/molecules30040851	2025
Enzymology	Isolation, identification, and biological characterization of bacterial endophytes isolated from Gunnera perpensa L.	Mahlangu SG, Zulu N, Serepa-Dlamini MH, Tai SL.	FEMS Microbiol Lett	10.1093/femsle/fnae056	2024
	Phytochemical analysis and biological activities of solvent extracts and silver nanoparticles obtained from Woodwardia unigemmata (Makino) Nakai.	Shah SA, Gul A, Shah GM, Wizrah MSI, Khalid A, Munir M, Maqbool Z, Aftab A, Alrahili MR, Siddiqua A, Begum MY.	PLoS One	10.1371/journal.pone.0312567	2025
	Genomic and Proteomic Analysis of Six Vi01-like Phages Reveals Wide Host Range and Multiple Tail Spike Proteins.	Harris EB, Ewool KKK, Bowden LC, Fierro J, Johnson D, Meinzer M, Tayler S, Grose JH.	Viruses	10.3390/v16020289	2024
	Biogenic Silver Nanoparticles Strategically Combined With Origanum vulgare Derivatives: Antibacterial Mechanism of Action and Effect on Multidrug-Resistant Strains.	Scandorieiro S, Rodrigues BCD, Nishio EK, Panagio LA, de Oliveira AG, Duran N, Nakazato G, Kobayashi RKT.	Front Microbiol	10.3389/fmicb.2022.842600	2022
	Pharmacological Studies on the Antidiabetic, Antioxidant, and Antimicrobial Efficacies of Commiphora myrrha Resin in Streptozotocin-Induced Diabetes in Rats: A Preclinical Study.	Mansouri RA, Ahmad A, Roushdy M M, Alshaibi HF, Ragab M.	J Diabetes Res	10.1155/2023/5478267	2023
Pathogenicity	Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats.	Qu S, Dai C, Yang F, Huang T, Hao Z, Tang Q, Wang H, Zhang Y.	Pharm Res	10.1007/s11095-019-2614-7	2019
	Essential Oil Biodiversity of Achillea ligustica All. Obtained from Mainland and Island Populations.	Bader A, AlQathama A, Cioni PL, Ceccarini L, Abdelhady MIS, Al-Shareef W, Ascrizzi R, Flamini G.	Plants (Basel)	10.3390/plants11081054	2022
	Chemical Composition and Antimicrobial Activity of Subcritical CO₂ Extract of Lepidium latifolium L. (Brassicaceae).	Azimkhanova BB, Ustenova GO, Sharipov KO, Rakhimov KD, Sayakova GM, Jumagaziyeva AB, Flisyuk EV, Gemejiyeva NG.	Int J Biomater	10.1155/2021/4389967	2021
	Outer Membrane Vesicles Derived from Klebsiella pneumoniae Are a Driving Force for Horizontal Gene Transfer.	Dell'Annunziata F, Dell'Aversana C, Doti N, Donadio G, Dal Piaz F, Izzo V, De Filippis A, Galdiero M, Altucci L, Boccia G, Galdiero M, Folliero V, Franci G.	Int J Mol Sci	10.3390/ijms22168732	2021
	Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.	Pacios O, Fernandez-Garcia L, Bleriot I, Blasco L, Gonzalez-Bardanca M, Lopez M, Fernandez-Cuenca F, Oteo J, Pascual A, Martinez-Martinez L, Domingo-Calap P, Bou G, Tomas M, Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).	Antimicrob Agents Chemother	10.1128/aac.00900-21	2021
Genetics	Genomic and in-vitro characteristics of a novel strain Lacticaseibacillus chiayiensis AACE3 isolated from fermented blueberry.	Li XD, Lin YC, Yang RS, Kang X, Xin WG, Wang F, Zhang QL, Zhang WP, Lin LB.	Front Microbiol	10.3389/fmicb.2023.1168378	2023
	Large-scale production of myco-fabricated ZnO/MnO nanocomposite using endophytic Colonstachys rosea with its antimicrobial efficacy against human pathogens.	El-Moslamy SH, Abd-Elhamid AI, Fawal GE.	Sci Rep	10.1038/s41598-024-51398-9	2024
	Intestinal Klebsiella pneumoniae Contributes to Pneumonia by Synthesizing Glutamine in Multiple Myeloma.	Wang Y, Yang Q, Zhu Y, Jian X, Guo J, Zhang J, Kuang C, Feng X, An G, Qiu L, Li G, He Y, Zhou W.	Cancers (Basel)	10.3390/cancers14174188	2022
	Antibiotic Activity Potentiation and Physicochemical Characterization of the Fixed Orbignya speciosa Almond Oil against MDR Staphylococcus aureus and Other Bacteria.	Machado JF, do Socorro Costa M, Tintino SR, Rodrigues FFG, Nobre CB, Coutinho HDM, da Costa JGM, de Menezes IRA, de Sousa EO.	Antibiotics (Basel)	10.3390/antibiotics8010028	2019
	Phytochemical and biological activities of some Iranian medicinal plants.	Dini S, Chen Q, Fatemi F, Asri Y.	Pharm Biol	10.1080/13880209.2022.2046112	2022
	Influence of Plant Part Selection and Drying Technique: Exploration and Optimization of Antioxidant and Antibacterial Activities of New Guinea Impatiens Extracts.	Delgado Rodriguez F, Azofeifa G, Quesada S, Weng Huang NT, Loria Gutierrez A, Morales Rojas MF.	Plants (Basel)	10.3390/plants14071092	2025
	Discovery of a Series of Indane-Containing NBTIs with Activity against Multidrug-Resistant Gram-Negative Pathogens.	Cumming JG, Kreis L, Kuhne H, Wermuth R, Vercruysse M, Kramer C, Rudolph MG, Xu Z.	ACS Med Chem Lett	10.1021/acsmedchemlett.3c00187	2023
	Bioactive compounds, antibacterial and antioxidant activities of methanol extract of Tamarindus indica Linn.	Fagbemi KO, Aina DA, Adeoye-Isijola MO, Naidoo KK, Coopoosamy RM, Olajuyigbe OO.	Sci Rep	10.1038/s41598-022-13716-x	2022
	Genomic Sequence of Klebsiella pneumoniae IIEMP-3, a Vitamin B12-Producing Strain from Indonesian Tempeh.	Yulandi A, Sugiokto FG, Febrilina, Suwanto A.	Genome Announc	10.1128/genomea.01724-15	2016
	New Insights into the Mechanism of Antibacterial Action of Synthetic Peptide Mo-CBP₃-PepI against Klebsiella pneumoniae.	Branco LAC, Souza PFN, Neto NAS, Aguiar TKB, Silva AFB, Carneiro RF, Nagano CS, Mesquita FP, Lima LB, Freitas CDT.	Antibiotics (Basel)	10.3390/antibiotics11121753	2022
	Ellagitannin, Phenols, and Flavonoids as Antibacterials from Acalypha arvensis (Euphorbiaceae).	Ble-Gonzalez EA, Gomez-Rivera A, Zamilpa A, Lopez-Rodriguez R, Lobato-Garcia CE, Alvarez-Fitz P, Gutierrez-Roman AS, Perez-Garcia MD, Bugarin A, Gonzalez-Cortazar M.	Plants (Basel)	10.3390/plants11030300	2022
	Beta-Lactam Sensitive Bacteria Can Acquire ESBL-Resistance via Conjugation after Long-Term Exposure to Lethal Antibiotic Concentration.	Ruotsalainen P, Given C, Penttinen R, Jalasvuori M.	Antibiotics (Basel)	10.3390/antibiotics9060296	2020
	From by-products to new application opportunities: the enhancement of the leaves deriving from the fruit plants for new potential healthy products.	Regolo L, Giampieri F, Battino M, Armas Diaz Y, Mezzetti B, Elexpuru-Zabaleta M, Mazas C, Tutusaus K, Mazzoni L.	Front Nutr	10.3389/fnut.2024.1083759	2024
	Therapeutic Potential of an Azithromycin-Colistin Combination against XDR K. pneumoniae in a 3D Collagen-Based In Vitro Wound Model of a Biofilm Infection.	Moshynets OV, Baranovskyi TP, Iungin OS, Krikunov AA, Potochilova VV, Rudnieva KL, Potters G, Pokholenko I.	Antibiotics (Basel)	10.3390/antibiotics12020293	2023
	New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents.	Saleh M, Mostafa YA, Kumari J, Thabet MM, Sriram D, Kandeel M, Abdu-Allah HHM.	RSC Med Chem	10.1039/d3md00449j	2023
Metabolism	GC-MS-Based Metabolomics Study of Single- and Dual-Species Biofilms of Candida albicans and Klebsiella pneumoniae.	Galdiero E, Salvatore MM, Maione A, de Alteriis E, Andolfi A, Salvatore F, Guida M.	Int J Mol Sci	10.3390/ijms22073496	2021
	Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model.	Babu L, Uppalapati SR, Sripathy MH, Reddy PN.	Front Microbiol	10.3389/fmicb.2017.01805	2017
	Challenge in the Discovery of New Drugs: Antimicrobial Peptides against WHO-List of Critical and High-Priority Bacteria.	Roque-Borda CA, da Silva PB, Rodrigues MC, Azevedo RB, Di Filippo L, Duarte JL, Chorilli M, Festozo Vicente E, Pavan FR.	Pharmaceutics	10.3390/pharmaceutics13060773	2021
	Investigating the Antibacterial Activity and Safety of Zinc Oxide Nanoparticles versus a Commercial Alcohol-Based Hand-Sanitizer: Can Zinc Oxide Nanoparticles Be Useful for Hand Sanitation?	Ismail A, Raya NR, Orabi A, Ali AM, Abo-Zeid Y.	Antibiotics (Basel)	10.3390/antibiotics11111606	2022
	Effect of the Harvest Season of Anthyllis henoniana Stems on Antioxidant and Antimicrobial Activities: Phytochemical Profiling of Their Ethyl Acetate Extracts.	Ayachi A, Ben Younes A, Ben Ammar A, Bouzayani B, Samet S, Siala M, Trigui M, Treilhou M, Tene N, Mezghani-Jarraya R.	Molecules	10.3390/molecules28093947	2023
	Development of a Rapid and Efficient RPA-CRISPR/Cas12a Assay for Mycoplasma pneumoniae Detection.	Li F, Xiao J, Yang H, Yao Y, Li J, Zheng H, Guo Q, Wang X, Chen Y, Guo Y, Wang Y, Shen C.	Front Microbiol	10.3389/fmicb.2022.858806	2022
	Correlation of quinolone-resistance, qnr genes and integron carriage in multidrug-resistant community isolates of Klebsiella spp.	Malek Jamshidi MR, Zandi H, Eftekhar F.	Iran J Basic Med Sci	10.22038/ijbms.2019.13985	2019
	Design, Synthesis, Molecular Modeling, Biological Activity, and Mechanism of Action of Novel Amino Acid Derivatives of Norfloxacin.	Kamal El-Sagheir AM, Abdelmesseh Nekhala I, Abd El-Gaber MK, Aboraia AS, Persson J, Schafer AB, Wenzel M, Omar FA.	ACS Omega	10.1021/acsomega.3c07221	2023
	A GC-MC analysis of chemical compounds and identification of the antibacterial characteristics of the essential oil of two species exclusive to Iranian habitats: New chemotypes.	Ghavam M.	PLoS One	10.1371/journal.pone.0273987	2022
	Impact of the Peptide WMR-K on Dual-Species Biofilm Candida albicans/Klebsiella pneumoniae and on the Untargeted Metabolomic Profile.	Galdiero E, Salvatore MM, Maione A, Carraturo F, Galdiero S, Falanga A, Andolfi A, Salvatore F, Guida M.	Pathogens	10.3390/pathogens10020214	2021
	Antimicrobial Properties of the Triclosan-Loaded Polymeric Composite Based on Unsaturated Polyester Resin: Synthesis, Characterization and Activity.	Tauanov Z, Zakiruly O, Baimenova Z, Baimenov A, Akimbekov NS, Berillo D.	Polymers (Basel)	10.3390/polym14040676	2022
	Antimicrobial Activity the Essential Oil from Croton pluriglandulosus Carn. Leaves against Microorganisms of Clinical Interest.	Carvalho RJP, Souza PFN, Malveira EA, Neto NAS, Silva RRS, Melo GLC, Silva AFB, Lima LB, de Albuquerque CC, Bastos RW, Goldman GH, de Freitas CDT.	J Fungi (Basel)	10.3390/jof9070756	2023
	Repurposing Selamectin as an Antimicrobial Drug against Hospital-Acquired Staphylococcus aureus Infections.	Folliero V, Dell'Annunziata F, Santella B, Roscetto E, Zannella C, Capuano N, Perrella A, De Filippis A, Boccia G, Catania MR, Galdiero M, Franci G.	Microorganisms	10.3390/microorganisms11092242	2023
	Optimisation of preparation conditions for Ti nanowires and suitability as an antibacterial material.	Munisparan T, Yang ECY, Paramasivam R, Dahlan NA, Pushpamalar J.	IET Nanobiotechnol	10.1049/iet-nbt.2017.0186	2018
	N4-Substituted Piperazinyl Norfloxacin Derivatives with Broad-Spectrum Activity and Multiple Mechanisms on Gyrase, Topoisomerase IV, and Bacterial Cell Wall Synthesis.	Kamal El-Sagheir AM, Abdelmesseh Nekhala I, Abd El-Gaber MK, Aboraia AS, Persson J, Schafer AB, Wenzel M, Omar FA.	ACS Bio Med Chem Au	10.1021/acsbiomedchemau.3c00038	2023
Enzymology	Production of Collagens and Protein Hydrolysates with Antimicrobial and Antioxidant Activity from Sheep Slaughter By-Products.	Vidal AR, Cansian RL, Mello RO, Demiate IM, Kempka AP, Dornelles RCP, Rodriguez JML, Campagnol PCB.	Antioxidants (Basel)	10.3390/antiox11061173	2022
	Enhancing the antimycobacterial efficacy of pyridine-4-carbohydrazide: linkage to additional antimicrobial agents via oxocarboxylic acids.	Pflegr V, Konecna K, Stolarikova J, Osterreicher J, Jandourek O, Kratky M.	RSC Med Chem	10.1039/d4md00663a	2025
Pathogenicity	Phytochemicals and Bioactivities of Zingiber cassumunar Roxb.	Han AR, Kim H, Piao D, Jung CH, Seo EK.	Molecules	10.3390/molecules26082377	2021
	Septicemic invasive Klebsiella pneumoniae infection in a cynomolgus monkey (Macaca fascicularis) with severe diffused suppurative meningoencephalitis.	Kasuya K, Takayama K, Bito M, Shimokubo N, Kawashima R, Shibahara T.	J Vet Med Sci	10.1292/jvms.17-0126	2017
	Clove Polyphenolic Compounds Improve the Microbiological Status, Lipid Stability, and Sensory Attributes of Beef Burgers during Cold Storage.	Ahmed IAM, Babiker EE, Al-Juhaimi FY, Bekhit AEA.	Antioxidants (Basel)	10.3390/antiox11071354	2022
	Design, synthesis, antimicrobial, antibiofilm evaluation and Z/E-isomerization of novel 6-((arylamino)methylene)benzo[a] phenazin-5(6H)-ones induced by organic solvent.	Olyaei A, Ghaleghovandi N, Moghadami F, Sadeghpour M, Abediha S.	RSC Adv	10.1039/d3ra05788g	2023
	Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption.	Assis LR, Theodoro RDS, Costa MBS, Nascentes JAS, Rocha MDD, Bessa MAS, Menezes RP, Dilarri G, Hypolito GB, Santos VRD, Duque C, Ferreira H, Martins CHG, Regasini LO.	Membranes (Basel)	10.3390/membranes12030269	2022
	Traditional Uses, Phytochemistry, and Bioactivities of Mesosphaerum suaveolens (L.) Kuntze.	Almeida-Bezerra JW, Rodrigues FC, Lima Bezerra JJ, Vieira Pinheiro AA, Almeida de Menezes S, Tavares AB, Costa AR, Augusta de Sousa Fernandes P, Bezerra da Silva V, Martins da Costa JG, Pereira da Cruz R, Bezerra Morais-Braga MF, Melo Coutinho HD, Teixeira de Albergaria E, Meiado MV, Siyadatpanah A, Kim B, Morais de Oliveira AF.	Evid Based Complement Alternat Med	10.1155/2022/3829180	2022
	Chemotype of damask rose with oleic acid (9 octadecenoic acid) and its antimicrobial effectiveness.	Ghavam M, Afzali A, Manca ML.	Sci Rep	10.1038/s41598-021-87604-1	2021
	Evaluation of a micro/nanofluidic chip platform for diagnosis of central nervous system infections: a multi-center prospective study.	Zheng G, Zhang Y, Zhang L, Qian L, Cai Y, Lv H, Kang X, Guo D, Wang X, Huang J, Gao Z, Guan X, Zhang G.	Sci Rep	10.1038/s41598-020-58670-8	2020
	Chemical composition and antimicrobial activity of essential oils obtained from leaves and flowers of Salvia hydrangea DC. ex Benth.	Ghavam M, Manca ML, Manconi M, Bacchetta G.	Sci Rep	10.1038/s41598-020-73193-y	2020
	Prevalence of Extended-Spectrum beta-lactamase and Integron Gene Carriage in Multidrug-Resistant Klebsiella Species Isolated from Outpatients in Yazd, Iran.	Malekjamshidi MR, Zandi H, Eftekhar F.	Iran J Med Sci	10.30476/ijms.2019.45334	2020
	Thiamine Demonstrates Bio-Preservative and Anti-Microbial Effects in Minced Beef Meat Storage and Lipopolysaccharide (LPS)-Stimulated RAW 264.7 Macrophages.	Hsouna AB, Boye A, Ackacha BB, Dhifi W, Saad RB, Brini F, Mnif W, Kacaniova M.	Animals (Basel)	10.3390/ani12131646	2022
	The effect of UV radiation on O-7 Actinomycete in producing bioactive compounds in different growth conditions.	Ibnouf EO.	Saudi J Biol Sci	10.1016/j.sjbs.2021.04.070	2021
	Green synthesis, characterization, enhanced functionality and biological evaluation of silver nanoparticles based on Coriander sativum.	Alsubki R, Tabassum H, Abudawood M, Rabaan AA, Alsobaie SF, Ansar S.	Saudi J Biol Sci	10.1016/j.sjbs.2020.12.055	2021
	Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives.	Huang B, Zhang Y.	Drug Discov Today	10.1016/j.drudis.2022.02.007	2022
	Turmeric extract-mediated biogenic synthesis of Ag@SeO₂ magnetic nanoparticles: characterization, optimization, antibacterial and antioxidant activities.	Ghoniem AA, Elattar KM, Al-Otibi FO, Elsayed A, El-Hersh MS, El-Khateeb AY, Helmy YA, Saber WIA.	RSC Adv	10.1039/d4ra00004h	2024
	Antimicrobial Properties of Chilean Native Plants: Future Aspects in Their Application in the Food Industry.	Otero MC, Fuentes JA, Atala C, Cuadros-Orellana S, Fuentes C, Gordillo-Fuenzalida F.	Foods	10.3390/foods11121763	2022
Pathogenicity	Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria.	Jian X, Zhu Y, Ouyang J, Wang Y, Lei Q, Xia J, Guan Y, Zhang J, Guo J, He Y, Wang J, Li J, Lin J, Su M, Li G, Wu M, Qiu L, Xiang J, Xie L, Jia W, Zhou W, Zhou W.	Microbiome	10.1186/s40168-020-00854-5	2020
	Broad-Spectrum Antimicrobial Activity of Oftasecur and Visuprime Ophthalmic Solutions.	Dell'Annunziata F, Morone MV, Gioia M, Cione F, Galdiero M, Rosa N, Franci G, De Bernardo M, Folliero V.	Microorganisms	10.3390/microorganisms11020503	2023
	Coumarin-piperazine derivatives as biologically active compounds.	Ostrowska K.	Saudi Pharm J	10.1016/j.jsps.2019.11.025	2020
Metabolism	Discovery of anti-infective adipostatins through bioactivity-guided isolation and heterologous expression of a type III polyketide synthase.	Hou L, Li Y, Wu Q, Li M, Older EA, Tang X, Nagarkatti P, Nagarkatti M, Liu Y, Li L, Fan D, Bugni TS, Shang Z, Li J.	Bioorg Chem	10.1016/j.bioorg.2021.104925	2021
	Molecular characterization, serotypes and phenotypic and genotypic evaluation of antibiotic resistance of the Klebsiella pneumoniae strains isolated from different types of hospital-acquired infections.	Ranjbar R, Fatahian Kelishadrokhi A, Chehelgerdi M.	Infect Drug Resist	10.2147/idr.s199639	2019
	Investigation of the Antibiofilm Effects of Mentha longifolia Essential Oil on Titanium and Stainless Steel Orthopedic Implant Surfaces.	Pazarci O, Tutar U, Kilinc S.	Eurasian J Med	10.5152/eurasianjmed.2019.18432	2019
	Multiplexed detection of respiratory pathogens with a portable analyzer in a "raw-sample-in and answer-out" manner.	Li N, Shen M, Liu J, Zhang L, Wang H, Xu Y, Cheng J.	Microsyst Nanoeng	10.1038/s41378-021-00321-7	2021
	Broad spectrum of beta-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new beta-lactam/beta-lactamase inhibitor combinations.	Sanchez-Pena L, Rodriguez-Pallares S, Aja-Macaya P, Blanco-Martin T, Gonzalez-Pinto L, Perez-Rodriguez G, Le Terrier C, Portillo-Calderon I, Recacha E, Riazzo C, Vazquez-Ucha JC, Beceiro A, Aracil B, Oteo-Iglesias J, Martinez-Martinez L, Poirel L, Bou G, Arca-Suarez J.	Antimicrob Agents Chemother	10.1128/aac.00533-25	2025
	Aspartate alpha-decarboxylase a new therapeutic target in the fight against Helicobacter pylori infection.	Ibrahim KA, Kashef MT, Elkhamissy TR, Ramadan MA, Helmy OM.	Front Microbiol	10.3389/fmicb.2022.1019666	2022
	In Vitro Antimicrobial Effects and Inactivation Mechanisms of 5,8-Dihydroxy-1,4-Napthoquinone.	Topcu S, Seker MG.	Antibiotics (Basel)	10.3390/antibiotics11111537	2022
	Potential Pharmacological Properties of Triterpene Derivatives of Ursolic Acid.	Khwaza V, Aderibigbe BA.	Molecules	10.3390/molecules29163884	2024
Phylogeny	Diversity and Antimicrobial Activity of Culturable Fungal Endophytes in Solanum mauritianum.	Pelo S, Mavumengwana V, Green E.	Int J Environ Res Public Health	10.3390/ijerph17020439	2020
	Characterization of the seminal bacterial microbiome of healthy, fertile stallions using next-generation sequencing.	Quinones-Perez C, Hidalgo M, Ortiz I, Crespo F, Vega-Pla JL.	Anim Reprod	10.1590/1984-3143-ar2020-0052	2021
	Modulation of the Antibiotic Activity by the Mauritia flexuosa (Buriti) Fixed Oil against Methicillin-Resistant Staphylococcus Aureus (MRSA) and Other Multidrug-Resistant (MDR) Bacterial Strains.	Faustino Pereira Y, do Socorro Costa M, Relison Tintino S, Esmeraldo Rocha J, Fernandes Galvao Rodrigues F, de Sa Barreto Feitosa MK, de Menezes IRA, Douglas Melo Coutinho H, da Costa JGM, de Sousa EO.	Pathogens	10.3390/pathogens7040098	2018
	Phytochemical composition, and cytotoxic, antioxidant, and antibacterial activity of the essential oil and methanol extract of Semenovia suffruticosa.	Soltanian S, Mohamadi N, Rajaei P, Khodami M, Mohammadi M.	Avicenna J Phytomed		2019
Pathogenicity	Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance.	Spohn R, Daruka L, Lazar V, Martins A, Vidovics F, Grezal G, Mehi O, Kintses B, Szamel M, Jangir PK, Csorgo B, Gyorkei A, Bodi Z, Farago A, Bodai L, Foldesi I, Kata D, Maroti G, Pap B, Wirth R, Papp B, Pal C.	Nat Commun	10.1038/s41467-019-12364-6	2019
	Antimicrobial Applications of Green Synthesized Bimetallic Nanoparticles from Ocimum basilicum.	More PR, Zannella C, Folliero V, Foglia F, Troisi R, Vergara A, Franci G, De Filippis A, Galdiero M.	Pharmaceutics	10.3390/pharmaceutics14112457	2022
Phylogeny	Stemodane Diterpenes and Diterpenoids: Isolation, Structure Elucidation, Biogenesis, Biosynthesis, Biological Activity, Biotransformations, Metabolites and Derivatives Biological Activity, Rearrangements.	Leonelli F, Migneco LM, Valletta A, Marini Bettolo R.	Molecules	10.3390/molecules26092761	2021
	Selection and validation of reference genes for gene expression studies in Klebsiella pneumoniae using Reverse Transcription Quantitative real-time PCR.	Gomes AEI, Stuchi LP, Siqueira NMG, Henrique JB, Vicentini R, Ribeiro ML, Darrieux M, Ferraz LFC.	Sci Rep	10.1038/s41598-018-27420-2	2018
Pathogenicity	Himatanthus drasticus Leaves: Chemical Characterization and Evaluation of Their Antimicrobial, Antibiofilm, Antiproliferative Activities.	Figueiredo CSSES, Branco Santos JC, Castro Junior JAA, Wakui VG, Rodrigues JFS, Arruda MO, Monteiro AS, Monteiro-Neto V, Bomfim MRQ, Kato L, Nascimento da Silva LC, Grisotto MAG.	Molecules	10.3390/molecules22060910	2017
	Naturally occurring prenylated flavonoids from African Erythrina plant species.	Tsakem B, Ntie Kang F, Teponno RB, Siwe Noundou X.	RSC Adv	10.1039/d5ra03457d	2025
Metabolism	Structural basis of the UDP-diacylglucosamine pyrophosphohydrolase LpxH inhibition by sulfonyl piperazine antibiotics.	Cho J, Lee M, Cochrane CS, Webster CG, Fenton BA, Zhao J, Hong J, Zhou P.	Proc Natl Acad Sci U S A	10.1073/pnas.1912876117	2020
	An In Vitro and In Silico Characterization of Salvia sclarea L. Methanolic Extracts as Spasmolytic Agents.	Randjelovic M, Brankovic S, Jovanovic M, Kitic N, Zivanovic S, Mihajilov-Krstev T, Miladinovic B, Milutinovic M, Kitic D.	Pharmaceutics	10.3390/pharmaceutics15051376	2023
	Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation.	Durcik M, Skok Z, Ilas J, Zidar N, Zega A, Szili PE, Draskovits G, Revesz T, Kikelj D, Nyerges A, Pal C, Masic LP, Tomasic T.	Pharmaceutics	10.3390/pharmaceutics13010006	2020
Enzymology	Enhancement of active ingredients and biological activities of Nostoc linckia biomass cultivated under modified BG-11₀ medium composition.	El-Fayoumy EA, Shanab SM, Hassan OMA, Shalaby EA.	Biomass Convers Biorefin	10.1007/s13399-021-01509-7	2023
Metabolism	Discovery of Three Toxic Proteins of Klebsiella Phage fHe-Kpn01.	Spruit CM, Wicklund A, Wan X, Skurnik M, Pajunen MI.	Viruses	10.3390/v12050544	2020
	Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors.	Kratky M, Stepankova S, Konecna K, Svrckova K, Maixnerova J, Svarcova M, Jandourek O, Trejtnar F, Vinsova J.	Pharmaceuticals (Basel)	10.3390/ph14121229	2021
	Chemical Constituents and Their Biological Activities from Genus Styrax.	Xia DD, Han XY, Zhang Y, Zhang N.	Pharmaceuticals (Basel)	10.3390/ph16071043	2023
	New Verticillene Diterpenoids, Eudesmane Sesquiterpenoids, and Hydroperoxysteroids from the Further Chemical Investigation of a Taiwanese Soft Coral Cespitularia sp.	Fu CW, Lin YC, Chiou SF, Chen SL, Lin CC, Wang HC, Dai CF, Sheu JH.	Molecules	10.3390/molecules28041521	2023
	Prevalence of qnr and aac(6')-Ib-cr Genes in Clinical Isolates of Klebsiella Pneumoniae from Imam Hussein Hospital in Tehran.	Eftekhar F, Seyedpour SM.	Iran J Med Sci		2015
	Ethnobotany, Phytochemistry, Biological, and Nutritional Properties of Genus Crepis-A Review.	Badalamenti N, Sottile F, Bruno M.	Plants (Basel)	10.3390/plants11040519	2022
	Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity.	Kan J, Morales-Amador A, Hernandez Y, Ternei MA, Lemetre C, Maclntyre LW, Biais N, Brady SF.	Elife	10.7554/elife.99281	2025
	The Lyophilization Process Maintains the Chemical and Biological Characteristics of Royal Jelly.	Nascimento AP, Moraes LA, Ferreira NU, Moreno Gde P, Uahib FG, Barizon EA, Berretta AA.	Evid Based Complement Alternat Med	10.1155/2015/825068	2015
	Marine Macrolides with Antibacterial and/or Antifungal Activity.	Karpinski TM.	Mar Drugs	10.3390/md17040241	2019
Enzymology	A New Micromonospora Strain with Antibiotic Activity Isolated from the Microbiome of a Mid-Atlantic Deep-Sea Sponge.	Back CR, Stennett HL, Williams SE, Wang L, Ojeda Gomez J, Abdulle OM, Duffy T, Neal C, Mantell J, Jepson MA, Hendry KR, Powell D, Stach JEM, Essex-Lopresti AE, Willis CL, Curnow P, Race PR.	Mar Drugs	10.3390/md19020105	2021
	Small Schiff Base Molecules-A Possible Strategy to Combat Biofilm-Related Infections.	Coanda M, Limban C, Nuta DC.	Antibiotics (Basel)	10.3390/antibiotics13010075	2024
	Metal complexes featuring a quinazoline schiff base ligand and glycine: synthesis, characterization, DFT and molecular docking analyses revealing their potent antibacterial, anti-helicobacter pylori, and Anti-COVID-19 activities.	Mansour MSA, Abdelkarim AT, El-Sherif AA, Mahmoud WH.	BMC Chem	10.1186/s13065-024-01239-7	2024
	Antitumor and Antibacterial Activity of Ni(II), Cu(II), Ag(I), and Hg(II) Complexes with Ligand Derived from Thiosemicarbazones: Characterization and Theoretical Studies.	Alshater H, Al-Sulami AI, Aly SA, Abdalla EM, Sakr MA, Hassan SS.	Molecules	10.3390/molecules28062590	2023
	Bridelia ferruginea Benth.; An ethnomedicinal, phytochemical, pharmacological and toxicological review.	Yeboah GN, Owusu FWA, Archer MA, Kyene MO, Kumadoh D, Ayertey F, Mintah SO, Atta-Adjei Junior P, Appiah AA.	Heliyon	10.1016/j.heliyon.2022.e10366	2022
	Donghaecyclinones A-C: New Cytotoxic Rearranged Angucyclinones from a Volcanic Island-Derived Marine Streptomyces sp.	Bae M, An JS, Hong SH, Bae ES, Chung B, Kwon Y, Hong S, Oh KB, Shin J, Lee SK, Oh DC.	Mar Drugs	10.3390/md18020121	2020
	New Imidazolium Alkaloids with Broad Spectrum of Action from the Marine Bacterium Shewanella aquimarina.	Giugliano R, Della Sala G, Buonocore C, Zannella C, Tedesco P, Palma Esposito F, Ragozzino C, Chianese A, Morone MV, Mazzella V, Nunez-Pons L, Folliero V, Franci G, De Filippis A, Galdiero M, de Pascale D.	Pharmaceutics	10.3390/pharmaceutics15082139	2023
	New Antimicrobial Phenyl Alkenoic Acids Isolated from an Oil Palm Rhizosphere-Associated Actinomycete, Streptomyces palmae CMU-AB204^T.	Sujarit K, Mori M, Dobashi K, Shiomi K, Pathom-Aree W, Lumyong S.	Microorganisms	10.3390/microorganisms8030350	2020
Pathogenicity	Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt.	Abouelfetouh A, Torky AS, Aboulmagd E.	Antimicrob Resist Infect Control	10.1186/s13756-019-0611-6	2019
	Antimicrobial, antioxidant and antitumor activities of silver nanoparticles synthesized by Allium cepa extract: A green approach.	Gomaa EZ.	J Genet Eng Biotechnol	10.1016/j.jgeb.2016.12.002	2017
	Compilation of the Antimicrobial Compounds Produced by Burkholderia Sensu Stricto.	Rodriguez-Cisneros M, Morales-Ruiz LM, Salazar-Gomez A, Rojas-Rojas FU, Estrada-de Los Santos P.	Molecules	10.3390/molecules28041646	2023
	Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics.	Catalano A, Iacopetta D, Pellegrino M, Aquaro S, Franchini C, Sinicropi MS.	Antibiotics (Basel)	10.3390/antibiotics10010092	2021
	Studies on Antibacterial Activity and Diversity of Cultivable Actinobacteria Isolated from Mangrove Soil in Futian and Maoweihai of China.	Li F, Liu S, Lu Q, Zheng H, Osterman IA, Lukyanov DA, Sergiev PV, Dontsova OA, Liu S, Ye J, Huang D, Sun C.	Evid Based Complement Alternat Med	10.1155/2019/3476567	2019
	Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.	Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H.	Molecules	10.3390/molecules21010062	2016
Enzymology	A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide^®) to the innovator brand in critically ill patients.	Mer M, Snyman JR, van Rensburg CE, van Tonder JJ, Laurens I.	Clin Pharmacol	10.2147/cpaa.s106676	2016
Pathogenicity	Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains.	Havenga B, Ndlovu T, Clements T, Reyneke B, Waso M, Khan W.	BMC Microbiol	10.1186/s12866-019-1687-0	2019
Pathogenicity	Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase.	Franci G, Folliero V, Cammarota M, Zannella C, Sarno F, Schiraldi C, de Lera AR, Altucci L, Galdiero M.	Sci Rep	10.1038/s41598-018-31135-9	2018
	Quinolone Susceptibility and Detection of qnr and aac(6')-Ib-cr Genes in Community Isolates of Klebsiella pneumoniae.	Seyedpour SM, Eftekhar F.	Jundishapur J Microbiol	10.5812/jjm.11136	2014
Genetics	A Novel, Highly Related Jumbo Family of Bacteriophages That Were Isolated Against Erwinia.	Sharma R, Pielstick BA, Bell KA, Nieman TB, Stubbs OA, Yeates EL, Baltrus DA, Grose JH.	Front Microbiol	10.3389/fmicb.2019.01533	2019
Metabolism	Structure-Guided Design of a Fluorescent Probe for the Visualization of FtsZ in Clinically Important Gram-Positive and Gram-Negative Bacterial Pathogens.	Ferrer-Gonzalez E, Fujita J, Yoshizawa T, Nelson JM, Pilch AJ, Hillman E, Ozawa M, Kuroda N, Al-Tameemi HM, Boyd JM, LaVoie EJ, Matsumura H, Pilch DS.	Sci Rep	10.1038/s41598-019-56557-x	2019
	Chromatographic Characterization and GC-MS Evaluation of the Bioactive Constituents with Antimicrobial Potential from the Pigmented Ink of Loligo duvauceli.	Girija S, Duraipandiyan V, Kuppusamy PS, Gajendran H, Rajagopal R.	Int Sch Res Notices	10.1155/2014/820745	2014
	Prevalence of Quinolone Resistance Among Extended-Spectrum beta -Lactamase Producing Uropathogenic Klebsiella pneumoniae.	Raei F, Eftekhar F, Feizabadi MM.	Jundishapur J Microbiol	10.5812/jjm.10887	2014
	Composition, Antioxidant Potential, and Antimicrobial Activity of Helichrysum plicatum DC. Various Extracts.	Vujic B, Vidakovic V, Jadranin M, Novakovic I, Trifunovic S, Tesevic V, Mandic B.	Plants (Basel)	10.3390/plants9030337	2020
	Development of a Melting-Curve-Based Multiplex Real-Time PCR Assay for the Simultaneous Detection of Viruses Causing Respiratory Infection.	Tavares ER, de Lima TF, Bartolomeu-Goncalves G, de Castro IM, de Lima DG, Borges PHG, Nakazato G, Kobayashi RKT, Venancio EJ, Tarley CRT, de Almeida ERD, Pelisson M, Vespero EC, Simao ANC, Perugini MRE, Kerbauy G, Fornazieri MA, Tognim MCB, Goes VM, Souza TACB, Oliveira DBL, Durigon EL, Faccin-Galhardi LC, Yamauchi LM, Yamada-Ogatta SF.	Microorganisms	10.3390/microorganisms11112692	2023
	Prevention of urinary catheter-associated infections by coating antimicrobial peptides from crowberry endophytes.	Monteiro C, Costa F, Pirttila AM, Tejesvi MV, Martins MCL.	Sci Rep	10.1038/s41598-019-47108-5	2019
	Bioprospecting for the soil-derived actinobacteria and bioactive secondary metabolites on the Western Qinghai-Tibet Plateau.	Liu L, Liu Y, Liu S, Nikandrova AA, Imamutdinova AN, Lukianov DA, Osterman IA, Sergiev PV, Zhang B, Zhang D, Li F, Sun C.	Front Microbiol	10.3389/fmicb.2023.1247001	2023
	Fermented yellow mombin juice using Lactobacillus acidophilus NRRL B-4495: Chemical composition, bioactive properties and survival in simulated gastrointestinal conditions.	Ribeiro ESS, Damasceno KSFSC, Dantas LMDC, Azevedo WM, Leite PIP, Assis CF, Sousa Junior FC.	PLoS One	10.1371/journal.pone.0239392	2020
Pathogenicity	Comparative analysis of quinolone resistance in clinical isolates of Klebsiella pneumoniae and Escherichia coli from Chinese children and adults.	Huang Y, Ogutu JO, Gu J, Ding F, You Y, Huo Y, Zhao H, Li W, Zhang Z, Zhang W, Chen X, Fu Y, Zhang F.	Biomed Res Int	10.1155/2015/168292	2015
	Complexation of uranyl (UO2)2+ with bidentate ligands: XRD, spectroscopic, computational, and biological studies.	Sharfalddin AA, Emwas AH, Jaremko M, Hussien MA.	PLoS One	10.1371/journal.pone.0256186	2021
	Diversity, novelty, antimicrobial activity, and new antibiotics of cultivable endophytic actinobacteria isolated from psammophytes collected from Taklamakan Desert.	Wang T, Li F, Lu Q, Wu G, Jiang Z, Liu S, Habden X, Razumova EA, Osterman IA, Sergiev PV, Dontsova OA, Hu X, You X, Sun C.	J Pharm Anal	10.1016/j.jpha.2020.06.004	2021
Pathogenicity	Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates.	Lombardo MN, G-Dayanandan N, Wright DL, Anderson AC.	ACS Infect Dis	10.1021/acsinfecdis.5b00129	2016
	Optimization and evaluation of a multiplex PCR assay for detection of Staphylococcus aureus and its major virulence genes for assessing food safety.	Nadiya S, Kolla HB, Reddy PN.	Braz J Microbiol	10.1007/s42770-023-00906-6	2023
Pathogenicity	Phytochemical composition and antimicrobial activities of the essential oils and organic extracts from Pelargonium graveolens growing in Tunisia.	Ben Hsouna A, Hamdi N.	Lipids Health Dis	10.1186/1476-511x-11-167	2012
	Antifouling coating based on biopolymers (PCL/ PLA) and bioactive extract from the sea cucumber Stichopus herrmanni.	Darya M, Abdolrasouli MH, Yousefzadi M, Sajjadi MM, Sourinejad I, Zarei M.	AMB Express	10.1186/s13568-022-01364-3	2022
	Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria.	Sagong HY, Rosado-Lugo JD, Bryan EJ, Ferrer-Gonzalez E, Wang Y, Cao Y, Parhi AK, Pilch DS, LaVoie EJ.	Med Chem Res	10.1007/s00044-022-02967-y	2022
	Antimicrobial Activity of Chitosan Oligosaccharides with Special Attention to Antiparasitic Potential.	Silva NSD, Araujo NK, Daniele-Silva A, Oliveira JWF, Medeiros JM, Araujo RM, Ferreira LS, Rocha HAO, Silva-Junior AA, Silva MS, Fernandes-Pedrosa MF.	Mar Drugs	10.3390/md19020110	2021
Pathogenicity	Integron mediated multidrug resistance in extended spectrum beta-lactamase producing clinical isolates of Klebsiella pneumoniae.	Mobarak-Qamsari M, Ashayeri-Panah M, Eftekhar F, Feizabadi MM.	Braz J Microbiol	10.1590/s1517-83822013000300028	2013
Pathogenicity	Interactions of antibiotics and methanolic crude extracts of Afzelia Africana (Smith.) against drug resistance bacterial isolates.	Aiyegoro O, Adewusi A, Oyedemi S, Akinpelu D, Okoh A.	Int J Mol Sci	10.3390/ijms12074477	2011
Pathogenicity	Pharmacological assessment of the medicinal potential of Acacia mearnsii De Wild.: antimicrobial and toxicity activities.	Olajuyigbe OO, Afolayan AJ.	Int J Mol Sci	10.3390/ijms13044255	2012
Pathogenicity	In vitro antibacterial and time-kill assessment of crude methanolic stem bark extract of Acacia mearnsii de wild against bacteria in shigellosis.	Olajuyigbe OO, Afolayan AJ.	Molecules	10.3390/molecules17022103	2012
Pathogenicity	Designed Antimicrobial Peptides Against Trauma-Related Cutaneous Invasive Fungal Wound Infections.	Woodburn KW, Jaynes JM, Clemens LE.	J Fungi (Basel)	10.3390/jof6030184	2020
	An ACE inhibitor reduces bactericidal activity of human neutrophils in vitro and impairs mouse neutrophil activity in vivo.	Cao DY, Giani JF, Veiras LC, Bernstein EA, Okwan-Duodu D, Ahmed F, Bresee C, Tourtellotte WG, Karumanchi SA, Bernstein KE, Khan Z.	Sci Transl Med	10.1126/scitranslmed.abj2138	2021
	The Antibacterial, Antitumor Activities, and Bioactive Constituents' Identification of Alectra sessiliflora Bacterial Endophytes.	Maela MP, van der Walt H, Serepa-Dlamini MH.	Front Microbiol	10.3389/fmicb.2022.870821	2022
	Anti-Planktonic and Anti-Biofilm Properties of Pentacyclic Triterpenes-Asiatic Acid and Ursolic Acid as Promising Antibacterial Future Pharmaceuticals.	Sycz Z, Tichaczek-Goska D, Wojnicz D.	Biomolecules	10.3390/biom12010098	2022
	Maltodextrin-induced intestinal injury in a neonatal mouse model.	Singh P, Sanchez-Fernandez LL, Ramiro-Cortijo D, Ochoa-Allemant P, Perides G, Liu Y, Medina-Morales E, Yakah W, Freedman SD, Martin CR.	Dis Model Mech	10.1242/dmm.044776	2020
Pathogenicity	Efficacy of surface disinfectant cleaners against emerging highly resistant gram-negative bacteria.	Reichel M, Schlicht A, Ostermeyer C, Kampf G.	BMC Infect Dis	10.1186/1471-2334-14-292	2014
	The Anti-Oxidant Curcumin Solubilized as Oil-in-Water Nanoemulsions or Chitosan Nanocapsules Effectively Reduces Helicobacter pylori Growth, Bacterial Biofilm Formation, Gastric Cell Adhesion and Internalization.	Hidalgo A, Bravo D, Soto C, Maturana G, Cordero-Machuca J, Zuniga-Lopez MC, Oyarzun-Ampuero F, Quest AFG.	Antioxidants (Basel)	10.3390/antiox12101866	2023
	Identification and enhancing production of a novel macrolide compound in engineered Streptomyces peucetius.	Pham VTT, Nguyen HT, Nguyen CT, Choi YS, Dhakal D, Kim TS, Jung HJ, Yamaguchi T, Sohng JK.	RSC Adv	10.1039/d0ra06099b	2021
	Optimization and comparative characterization of neuraminidase activities from Pseudomonas aeruginosa with Klebsiella pneumoniae, Hep-2 cell, sheep kidney and rat liver lysosome.	Ghazaei C, Ahmadi M, Hosseini Jazani N.	Iran J Microbiol		2010
	Early Antibiotic Exposure Alters Intestinal Development and Increases Susceptibility to Necrotizing Enterocolitis: A Mechanistic Study.	Chaaban H, Patel MM, Burge K, Eckert JV, Lupu C, Keshari RS, Silasi R, Regmi G, Trammell M, Dyer D, McElroy SJ, Lupu F.	Microorganisms	10.3390/microorganisms10030519	2022
	Lenzimycins A and B, Metabolites With Antibacterial Properties From Brevibacillus sp. Associated With the Dung Beetle Onthophagus lenzii.	An JS, Hong SH, Somers E, Lee J, Kim BY, Woo D, Kim SW, Hong HJ, Jo SI, Shin J, Oh KB, Oh DC.	Front Microbiol	10.3389/fmicb.2020.599911	2020
Genetics	Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance.	Nyerges A, Csorgo B, Draskovits G, Kintses B, Szili P, Ferenc G, Revesz T, Ari E, Nagy I, Balint B, Vasarhelyi BM, Bihari P, Szamel M, Balogh D, Papp H, Kalapis D, Papp B, Pal C.	Proc Natl Acad Sci U S A	10.1073/pnas.1801646115	2018
	Functionalized Calixarenes as Promising Antibacterial Drugs to Face Antimicrobial Resistance.	Mourer M, Regnouf-de-Vains JB, Duval RE.	Molecules	10.3390/molecules28196954	2023
	Neutrophil extracellular trap inhibition increases inflammation, bacteraemia and mortality in murine necrotizing enterocolitis.	Chaaban H, Burge K, Eckert J, Keshari RS, Silasi R, Lupu C, Warner B, Escobedo M, Caplan M, Lupu F.	J Cell Mol Med	10.1111/jcmm.15338	2021
	Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies.	Havenga B, Reyneke B, Waso-Reyneke M, Ndlovu T, Khan S, Khan W.	Microorganisms	10.3390/microorganisms10051052	2022
	Pharmacological and analytical aspects of alkannin/shikonin and their derivatives: An update from 2008 to 2022.	Kaur K, Sharma R, Singh A, Attri S, Arora S, Kaur S, Bedi N.	Chin Herb Med	10.1016/j.chmed.2022.08.001	2022
Enzymology	Bioactivity characterization of Lactobacillus strains isolated from dairy products.	Haghshenas B, Nami Y, Haghshenas M, Abdullah N, Rosli R, Radiah D, Khosroushahi AY.	Microbiologyopen	10.1002/mbo3.280	2015
	Development and Characterization of New Green Propolis Extract Formulations as Promising Candidates to Substitute for Green Propolis Hydroalcoholic Extract.	Berretta AA, Zamarrenho LG, Correa JA, De Lima JA, Borini GB, Ambrosio SR, Barud HDS, Bastos JK, De Jong D.	Molecules	10.3390/molecules28083510	2023
	Photorhabdus sp. ETL Antimicrobial Properties and Characterization of Its Secondary Metabolites by Gas Chromatography-Mass Spectrometry.	Lulamba TE, Green E, Serepa-Dlamini MH.	Life (Basel)	10.3390/life11080787	2021
	Antimicrobial activities and mechanisms of extract and components of herbs in East Asia.	Liang J, Huang X, Ma G.	RSC Adv	10.1039/d2ra02389j	2022
	Seasonal Variation in Essential Oils Composition and the Biological and Pharmaceutical Protective Effects of Mentha longifolia Leaves Grown in Tunisia.	Zouari-Bouassida K, Trigui M, Makni S, Jlaiel L, Tounsi S.	Biomed Res Int	10.1155/2018/7856517	2018
	Synergistic interactions of methanolic extract of Acacia mearnsii De Wild. with antibiotics against bacteria of clinical relevance.	Olajuyigbe OO, Afolayan AJ.	Int J Mol Sci	10.3390/ijms13078915	2012
	Antioxidant, antibacterial, and cytoprotective activity of agathi leaf protein.	Zarena AS, Gopal S, Vineeth R.	J Anal Methods Chem	10.1155/2014/989543	2014
	Biological Activities and the Essential Oil Analysis of Cousinia harazensis and C. calocephala.	Salimi-Sabour E, H Shirazi F, Mahboubi A, Mojab F, Irani M.	Iran J Pharm Res	10.22037/ijpr.2020.114155.14697	2021
	Relationships of irrigation water and soil physical and chemical characteristics with yield, chemical composition and antimicrobial activity of Damask rose essential oil.	Ghavam M.	PLoS One	10.1371/journal.pone.0249363	2021
	Biochemical Activities of Iranian Cymbopogon olivieri (Boiss) Bor. Essential Oil.	Mahboubi M, Kazempour N.	Indian J Pharm Sci	10.4103/0250-474x.107071	2012
	Bioprospecting of Actinobacterial Diversity and Antibacterial Secondary Metabolites from the Sediments of Four Saline Lakes on the Northern Tibetan Plateau.	Liu SW, Zhai XX, Liu D, Liu YY, Sui LY, Luo KK, Yang Q, Li FN, Nikandrova AA, Imamutdinova AN, Lukianov DA, Osterman IA, Sergiev PV, Zhang BY, Zhang DJ, Xue CM, Sun CH.	Microorganisms	10.3390/microorganisms11102475	2023
Pathogenicity	Evaluation of combination effects of ethanolic extract of Ziziphus mucronata Willd. subsp. mucronata Willd. and antibiotics against clinically important bacteria.	Olajuyigbe OO, Afolayan AJ.	ScientificWorldJournal	10.1155/2013/769594	2013
	An Updated Systematic Review of Vaccinium myrtillus Leaves: Phytochemistry and Pharmacology.	Stefanescu R, Laczko-Zold E, Osz BE, Vari CE.	Pharmaceutics	10.3390/pharmaceutics15010016	2022
Pathogenicity	Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products for intravenous administration.	Silva E, Diaz JA, Arias MJ, Hernandez AP, de la Torre A.	BMC Clin Pharmacol	10.1186/1472-6904-10-3	2010
	Antimicrobial and Wound Healing Potential of a New Chemotype from Piper cubeba L. Essential Oil and In Silico Study on S. aureus tyrosyl-tRNA Synthetase Protein.	Alminderej F, Bakari S, Almundarij TI, Snoussi M, Aouadi K, Kadri A.	Plants (Basel)	10.3390/plants10020205	2021
	Antimicrobial and Antioxidant Properties of Four Lycopus Taxa and an Interaction Study of Their Major Compounds.	Trajcikova E, Kurin E, Slobodnikova L, Straka M, Lichvarikova A, Dokupilova S, Cicova I, Nagy M, Mucaji P, Bittner Fialova S.	Molecules	10.3390/molecules25061422	2020
	Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane Permeability.	Bocsik A, Grof I, Kiss L, Otvos F, Zsiros O, Daruka L, Fulop L, Vastag M, Kittel A, Imre N, Martinek TA, Pal C, Szabo-Revesz P, Deli MA.	Pharmaceutics	10.3390/pharmaceutics11020073	2019
	Chemical composition and biological properties of Satureja avromanica Maroofi.	Abdali E, Javadi S, Akhgari M, Hosseini S, Dastan D.	J Food Sci Technol	10.1007/s13197-017-2512-0	2017
	Studies on Chemical Composition, Antimicrobial and Antioxidant Activities of Five Thymus vulgaris L. Essential Oils.	Mancini E, Senatore F, Del Monte D, De Martino L, Grulova D, Scognamiglio M, Snoussi M, De Feo V.	Molecules	10.3390/molecules200712016	2015
Metabolism	Antibiotic producing potentials of three freshwater actinomycetes isolated from the Eastern Cape Province of South Africa.	Sibanda T, Mabinya LV, Mazomba N, Akinpelu DA, Bernard K, Olaniran AO, Okoh AI.	Int J Mol Sci	10.3390/ijms11072612	2010
	Detection of new arr-4 and arr-5 gene cassettes in clinical Pseudomonas aeruginosa and Klebsiella pneumoniae strains from Brazil.	da Fonseca EL, Freitas Fdos S, de Amorim JC, Vicente AC.	Antimicrob Agents Chemother	10.1128/aac.00017-08	2008
	An in vitro synergistic interaction of combinations of Thymus glabrescens essential oil and its main constituents with chloramphenicol.	Ilic BS, Kocic BD, Ciric VM, Cvetkovic OG, Miladinovic DL.	ScientificWorldJournal	10.1155/2014/826219	2014
	Scaling-up strategies for controllable biosynthetic ZnO NPs using cell free-extract of endophytic Streptomyces albus: characterization, statistical optimization, and biomedical activities evaluation.	El-Moslamy SH, Elnouby MS, Rezk AH, El-Fakharany EM.	Sci Rep	10.1038/s41598-023-29757-9	2023
	Role of plasmid carrying bla _NDM in mediating antibiotic resistance among Acinetobacter baumannii clinical isolates from Egypt.	Abouelfetouh A, Torky AS, Aboulmagd E.	3 Biotech	10.1007/s13205-020-2157-y	2020
	Synergistic and Additive Effect of Oregano Essential Oil and Biological Silver Nanoparticles against Multidrug-Resistant Bacterial Strains.	Scandorieiro S, de Camargo LC, Lancheros CA, Yamada-Ogatta SF, Nakamura CV, de Oliveira AG, Andrade CG, Duran N, Nakazato G, Kobayashi RK.	Front Microbiol	10.3389/fmicb.2016.00760	2016
	Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations.	Dafale NA, Semwal UP, Agarwal PK, Sharma P, Singh GN.	J Pharm Anal	10.1016/j.jpha.2014.07.007	2015
	The effect of Acacia nilotica seed extract on the physicochemical, microbiological and oxidative stability of chicken patties.	Babiker EE, Al-Juhaimi FY, Alqah HA, Adisa AR, Adiamo OQ, Mohamed Ahmed IA, Alsawmahi ON, Ghafoor K, Ozcan MM.	J Food Sci Technol	10.1007/s13197-019-03862-y	2019
Pathogenicity	FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis.	Eckert J, Scott B, Lawrence SM, Ihnat M, Chaaban H.	J Inflamm Res	10.2147/jir.s131051	2017
	Caryocar coriaceum Wittm. (Caryocaraceae): Botany, Ethnomedicinal Uses, Biological Activities, Phytochemistry, Extractivism and Conservation Needs.	Almeida-Bezerra JW, Bezerra JJL, Silva VBD, Coutinho HDM, Costa JGMD, Cruz-Martins N, Hano C, Menezes SA, Morais-Braga MFB, Oliveira AFM.	Plants (Basel)	10.3390/plants11131685	2022
	Papaver Plants: Current Insights on Phytochemical and Nutritional Composition Along with Biotechnological Applications.	Butnariu M, Quispe C, Herrera-Bravo J, Pentea M, Sarac I, Kusumler AS, Ozcelik B, Painuli S, Semwal P, Imran M, Gondal TA, Emamzadeh-Yazdi S, Lapava N, Yousaf Z, Kumar M, Eid AH, Al-Dhaheri Y, Suleria HAR, Del Mar Contreras M, Sharifi-Rad J, Cho WC.	Oxid Med Cell Longev	10.1155/2022/2041769	2022
	Leaves Antimicrobial Activity of Glycyrrhiza glabra L.	Irani M, Sarmadi M, Bernard F, Ebrahimi Pour GH, Shaker Bazarnov H.	Iran J Pharm Res		2010
	Polymyxins-Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment.	Dai C, Wang Y, Sharma G, Shen J, Velkov T, Xiao X.	Antioxidants (Basel)	10.3390/antiox9060506	2020
	Antibacterial and antioxidant activities of ursolic acid and derivatives.	do Nascimento PG, Lemos TL, Bizerra AM, Arriaga AM, Ferreira DA, Santiago GM, Braz-Filho R, Costa JG.	Molecules	10.3390/molecules19011317	2014
	Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization.	Hansen N, Rasmussen AK, Fiandaca MJ, Kragh KN, Bjarnsholt T, Hoiby N, Stender H, Guardabassi L.	New Microbes New Infect	10.1002/nmi2.38	2014
Pathogenicity	Propolis standardized extract (EPP-AF®), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds.	Berretta AA, Nascimento AP, Bueno PC, Vaz MM, Marchetti JM.	Int J Biol Sci	10.7150/ijbs.3641	2012
	Fatty acid profile and in vitro biological properties of two Rosacea species (Pyrus glabra and Pyrus syriaca), grown as wild in Iran.	Hazrati S, Govahi M, Mollaei S.	Food Sci Nutr	10.1002/fsn3.1352	2020
Metabolism	Lipase and biosurfactant from Ochrobactrum intermedium strain MZV101 isolated by washing powder for detergent application.	Zarinviarsagh M, Ebrahimipour G, Sadeghi H.	Lipids Health Dis	10.1186/s12944-017-0565-8	2017
Enzymology	Phytochemical compositions and biological activities of essential oil from Xanthium strumarium L.	Sharifi-Rad J, Hoseini-Alfatemi SM, Sharifi-Rad M, Sharifi-Rad M, Iriti M, Sharifi-Rad M, Sharifi-Rad R, Raeisi S.	Molecules	10.3390/molecules20047034	2015
Enzymology	Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa.	Peleg AY, Tilahun Y, Fiandaca MJ, D'Agata EM, Venkataraman L, Moellering RC, Eliopoulos GM.	J Clin Microbiol	10.1128/jcm.01724-08	2009
Pathogenicity	Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea.	Mylonas A, Hawerkamp HC, Wang Y, Chen J, Messina F, Demaria O, Meller S, Homey B, Di Domizio J, Mazzolai L, Hovnanian A, Gilliet M, Conrad C.	JCI Insight	10.1172/jci.insight.151846	2023
	Biofilms: Novel Strategies Based on Antimicrobial Peptides.	Galdiero E, Lombardi L, Falanga A, Libralato G, Guida M, Carotenuto R.	Pharmaceutics	10.3390/pharmaceutics11070322	2019
	Development of a RPA-CRISPR-Cas12a Assay for Rapid, Simple, and Sensitive Detection of Mycoplasma hominis.	Chen J, Huang Y, Xiao B, Deng H, Gong K, Li K, Li L, Hao W.	Front Microbiol	10.3389/fmicb.2022.842415	2022
Phylogeny	Analysis of the 16S-23S rRNA gene internal transcribed spacer region in Klebsiella species.	Wang M, Cao B, Yu Q, Liu L, Gao Q, Wang L, Feng L.	J Clin Microbiol	10.1128/jcm.00927-08	2008
	Polymeric Carriers Designed for Encapsulation of Essential Oils with Biological Activity.	Chiriac AP, Rusu AG, Nita LE, Chiriac VM, Neamtu I, Sandu A.	Pharmaceutics	10.3390/pharmaceutics13050631	2021
Enzymology	Activity of Electrical Current in Experimental Propionibacterium acnes Foreign-Body Osteomyelitis.	Schmidt-Malan SM, Brinkman CL, Greenwood-Quaintance KE, Karau MJ, Mandrekar JN, Patel R.	Antimicrob Agents Chemother	10.1128/aac.01863-16	2017
	The Prophylactic Effect of Probiotic Enterococcus lactis IW5 against Different Human Cancer Cells.	Nami Y, Haghshenas B, Haghshenas M, Abdullah N, Yari Khosroushahi A.	Front Microbiol	10.3389/fmicb.2015.01317	2015
Pathogenicity	Antimicrobial activity of the solvent fractions from Bulbine natalensis Tuber.	Yakubu MT, Mostafa M, Ashafa AO, Afolayan AJ.	Afr J Tradit Complement Altern Med	10.4314/ajtcam.v9i4.2	2012
	Antimicrobial potential of Indian Cinnamomum species.	Singh B, Nathawat S, Avtar Sharma R.	Saudi J Biol Sci	10.1016/j.sjbs.2022.103549	2023
Enzymology	High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection.	Alves MS, da Silva Cariolano M, Dos Santos Ferreira HL, Sousa de Abreu Silva E, Felipe KKP, Monteiro SG, de Sousa EM, Abreu AG, Campbell LA, Rosenfeld ME, Hirata MH, Hirata RDC, Bastos GM, de Paula Abreu Silva IC, Lima-Neto LG.	Braz J Microbiol	10.1007/s42770-020-00229-w	2020
	Chemical composition and biological activities of the essential oils from three Melaleuca species grown in Tunisia.	Amri I, Mancini E, De Martino L, Marandino A, Lamia H, Mohsen H, Bassem J, Scognamiglio M, Reverchon E, De Feo V.	Int J Mol Sci	10.3390/ijms131216580	2012
	The Biological Activity and Composition of the Essential Oil of Sclerorhachis leptoclada (Asteraceae-Anthemideae) from Iran.	Sonboli A, Mirjalili MH, Hadian J, Yousefzadi M.	Iran J Pharm Res		2014
Enzymology	Detection of Enterobacter sakazakii and other pathogens associated with infant formula powder by use of a DNA microarray.	Wang M, Cao B, Gao Q, Sun Y, Liu P, Feng L, Wang L.	J Clin Microbiol	10.1128/jcm.00366-09	2009
	Metabolomics Tools Assisting Classic Screening Methods in Discovering New Antibiotics from Mangrove Actinomycetia in Leizhou Peninsula.	Lu QP, Huang YM, Liu SW, Wu G, Yang Q, Liu LF, Zhang HT, Qi Y, Wang T, Jiang ZK, Li JJ, Cai H, Liu XJ, Luo H, Sun CH.	Mar Drugs	10.3390/md19120688	2021
	An Optimized Synthetic-Bioinformatic Natural Product Antibiotic Sterilizes Multidrug-Resistant Acinetobacter baumannii-Infected Wounds.	Vila-Farres X, Chu J, Ternei MA, Lemetre C, Park S, Perlin DS, Brady SF.	mSphere	10.1128/msphere.00528-17	2018
	Angiotensin-converting enzyme enhances the oxidative response and bactericidal activity of neutrophils.	Khan Z, Shen XZ, Bernstein EA, Giani JF, Eriguchi M, Zhao TV, Gonzalez-Villalobos RA, Fuchs S, Liu GY, Bernstein KE.	Blood	10.1182/blood-2016-11-752006	2017
	Borrelidins C-E: New Antibacterial Macrolides from a Saltern-Derived Halophilic Nocardiopsis sp.	Kim J, Shin D, Kim SH, Park W, Shin Y, Kim WK, Lee SK, Oh KB, Shin J, Oh DC.	Mar Drugs	10.3390/md15060166	2017
	Chemical characterization, in vitro biological activity of essential oils and extracts of three Eryngium L. species and molecular docking of selected major compounds.	Matejic JS, Stojanovic-Radic ZZ, Ristic MS, Veselinovic JB, Zlatkovic BK, Marin PD, Dzamic AM.	J Food Sci Technol	10.1007/s13197-018-3209-8	2018
	Applications of Essential Oils as Antibacterial Agents in Minimally Processed Fruits and Vegetables-A Review.	Santos MIS, Marques C, Mota J, Pedroso L, Lima A.	Microorganisms	10.3390/microorganisms10040760	2022
Biotechnology	Lactobacillus species mediated synthesis of silver nanoparticles and their antibacterial activity against opportunistic pathogens in vitro.	Garmasheva I, Kovalenko N, Voychuk S, Ostapchuk A, Livins'ka O, Oleschenko L.	Bioimpacts	10.15171/bi.2016.29	2016
	Metabolic Engineering of Escherichia coli for Enhanced Production of Naringenin 7-Sulfate and Its Biological Activities.	Chu LL, Dhakal D, Shin HJ, Jung HJ, Yamaguchi T, Sohng JK.	Front Microbiol	10.3389/fmicb.2018.01671	2018
	Bromopyrrole Alkaloids from the Sponge Agelas kosrae.	Kwon OS, Kim D, Kim H, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Mar Drugs	10.3390/md16120513	2018
	Study on the antibacterial potential of physalis minima linn.	Patel T, Shah K, Jiwan K, Shrivastava N.	Indian J Pharm Sci	10.4103/0250-474x.89770	2011
Pathogenicity	Assessment of phytochemical content, polyphenolic composition, antioxidant and antibacterial activities of Leguminosae medicinal plants in Peninsular Malaysia.	Chew YL, Chan EW, Tan PL, Lim YY, Stanslas J, Goh JK.	BMC Complement Altern Med	10.1186/1472-6882-11-12	2011
	Filtration and Normalization of Sequencing Read Data in Whole-Metagenome Shotgun Samples.	Chouvarine P, Wiehlmann L, Moran Losada P, DeLuca DS, Tummler B.	PLoS One	10.1371/journal.pone.0165015	2016
Pathogenicity	A synthetic antibiotic class overcoming bacterial multidrug resistance.	Mitcheltree MJ, Pisipati A, Syroegin EA, Silvestre KJ, Klepacki D, Mason JD, Terwilliger DW, Testolin G, Pote AR, Wu KJY, Ladley RP, Chatman K, Mankin AS, Polikanov YS, Myers AG.	Nature	10.1038/s41586-021-04045-6	2021
	Antimicrobial and Antioxidant Activities of Pycnocycla spinosa Extracts.	Mahboubi M, Taghizadeh M, Kazempour N.	Jundishapur J Nat Pharm Prod	10.17795/jjnpp-13859	2014
	Phytochemistry, Toxicology and Therapeutic Value of Petasites hybridus Subsp. Ochroleucus (Common Butterbur) from the Balkans.	Mihajilov-Krstev T, Jovanovic B, Zlatkovic B, Matejic J, Vitorovic J, Cvetkovic V, Ilic B, Dordevic L, Jokovic N, Miladinovic D, Jaksic T, Stankovic N, Stankov Jovanovic V, Bernstein N.	Plants (Basel)	10.3390/plants9060700	2020
	Carbon Nanodot-Microbe-Plant Nexus in Agroecosystem and Antimicrobial Applications.	Prokisch J, Nguyen DHH, Muthu A, Ferroudj A, Singh A, Agrawal S, Rajput VD, Ghazaryan K, El-Ramady H, Rai M.	Nanomaterials (Basel)	10.3390/nano14151249	2024
Genetics	Improved bacterial recombineering by parallelized protein discovery.	Wannier TM, Nyerges A, Kuchwara HM, Czikkely M, Balogh D, Filsinger GT, Borders NC, Gregg CJ, Lajoie MJ, Rios X, Pal C, Church GM, Church GM.	Proc Natl Acad Sci U S A	10.1073/pnas.2001588117	2020
Enzymology	Depsidomycins B and C: New Cyclic Peptides from a Ginseng Farm Soil-Derived Actinomycete.	Kwon Y, Byun WS, Kim BY, Song MC, Bae M, Yoon YJ, Shin J, Lee SK, Oh DC.	Molecules	10.3390/molecules23061266	2018
	Inhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analogues.	Szychowski J, Kondo J, Zahr O, Auclair K, Westhof E, Hanessian S, Keillor JW.	ChemMedChem	10.1002/cmdc.201100346	2011
	Efficiency of Biosynthesized Silver and Zinc Nanoparticles Against Multi-Drug Resistant Pathogens.	Punjabi K, Mehta S, Chavan R, Chitalia V, Deogharkar D, Deshpande S.	Front Microbiol	10.3389/fmicb.2018.02207	2018
	Stilbenoids: A Natural Arsenal against Bacterial Pathogens.	Mattio LM, Catinella G, Dallavalle S, Pinto A.	Antibiotics (Basel)	10.3390/antibiotics9060336	2020
Pathogenicity	Rational design of balanced dual-targeting antibiotics with limited resistance.	Nyerges A, Tomasic T, Durcik M, Revesz T, Szili P, Draskovits G, Bogar F, Skok Z, Zidar N, Ilas J, Zega A, Kikelj D, Daruka L, Kintses B, Vasarhelyi B, Foldesi I, Kata D, Welin M, Kimbung R, Focht D, Masic LP, Pal C.	PLoS Biol	10.1371/journal.pbio.3000819	2020
	Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria.	Miller MJ, Walz AJ, Zhu H, Wu C, Moraski G, Mollmann U, Tristani EM, Crumbliss AL, Ferdig MT, Checkley L, Edwards RL, Boshoff HI.	J Am Chem Soc	10.1021/ja109665t	2011
	Exploitation of Potentially New Antibiotics from Mangrove Actinobacteria in Maowei Sea by Combination of Multiple Discovery Strategies.	Lu QP, Ye JJ, Huang YM, Liu D, Liu LF, Dong K, Razumova EA, Osterman IA, Sergiev PV, Dontsova OA, Jia SH, Huang DL, Sun CH.	Antibiotics (Basel)	10.3390/antibiotics8040236	2019
	Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety.	Mohammadhosseini N, Alipanahi Z, Alipour E, Emami S, Faramarzi MA, Samadi N, Khoshnevis N, Shafiee A, Foroumadi A.	Daru	10.1186/2008-2231-20-16	2012
Pathogenicity	Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.	Fujimoto K, Takemoto K, Hatano K, Nakai T, Terashita S, Matsumoto M, Eriguchi Y, Eguchi K, Shimizudani T, Sato K, Kanazawa K, Sunagawa M, Ueda Y.	Antimicrob Agents Chemother	10.1128/aac.01051-12	2013
	New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus.	Durcik M, Cotman AE, Toplak Z, Mozina S, Skok Z, Szili PE, Czikkely M, Maharramov E, Vu TH, Piras MV, Zidar N, Ilas J, Zega A, Trontelj J, Pardo LA, Hughes D, Huseby D, Berruga-Fernandez T, Cao S, Simoff I, Svensson R, Korol SV, Jin Z, Vicente F, Ramos MC, Mundy JEA, Maxwell A, Stevenson CEM, Lawson DM, Glinghammar B, Sjostrom E, Bohlin M, Oreskar J, Alver S, Janssen GV, Sterk GJ, Kikelj D, Pal C, Tomasic T, Peterlin Masic L.	J Med Chem	10.1021/acs.jmedchem.2c01905	2023
	Partial purification and characterization of an antimicrobial activity from the wood extract of mangrove plant Ceriops decandra.	Simlai A, Mukherjee K, Mandal A, Bhattacharya K, Samanta A, Roy A.	EXCLI J	10.17179/excli2015-741	2016
	NSAIDs as a Drug Repurposing Strategy for Biofilm Control.	Leao C, Borges A, Simoes M.	Antibiotics (Basel)	10.3390/antibiotics9090591	2020
	Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm.	Woodburn KW, Jaynes JM, Clemens LE.	Front Microbiol	10.3389/fmicb.2019.01688	2019
	Rapid diagnosis and simultaneous identification of tuberculous and bacterial meningitis by a newly developed duplex polymerase chain reaction.	Nagdev KJ, Bhagchandani SP, Bhullar SS, Kapgate RC, Kashyap RS, Chandak NH, Daginawala HF, Purohit HJ, Taori GM.	Indian J Microbiol	10.1007/s12088-015-0517-9	2015
	Parent and nano-encapsulated ytterbium(iii) complex toward binding with biological macromolecules, in vitro cytotoxicity, cleavage and antimicrobial activity studies.	Aramesh-Boroujeni Z, Jahani S, Khorasani-Motlagh M, Kerman K, Noroozifar M.	RSC Adv	10.1039/d0ra03895d	2020
	In vitro antibacterial and cytotoxic activity of leaf extracts of Centella asiatica (L.) Urb, Warburgia salutaris (Bertol. F.) Chiov and Curtisia dentata (Burm. F.) C.A.Sm - medicinal plants used in South Africa.	Soyingbe OS, Mongalo NI, Makhafola TJ.	BMC Complement Altern Med	10.1186/s12906-018-2378-3	2018
	In vitro Cytotoxic and Antimicrobial Activity of Essential Oil From Satureja Intermedia.	Sadeghi I, Yousefzadi M, Behmanesh M, Sharifi M, Moradi A.	Iran Red Crescent Med J	10.5812/ircmj.4989	2013
	Actinobaculum suis detection using polymerase chain reaction.	Amigo CR, Sena de Gobbi DD, Gomes VT, Perina Ddo P, Nogueira de Lima Filsner PH, Costa BL, Spindola MG, Ferreira TS, Brandao PE, Moreno AM.	ScientificWorldJournal	10.1100/2012/572732	2012
	In-vitro antibacterial properties of crude aqueous and n-hexane extracts of the husk of Cocos nucifera.	Akinyele TA, Okoh OO, Akinpelu DA, Okoh AI.	Molecules	10.3390/molecules16032135	2011
Pathogenicity	Evaluation of the antibacterial potential of Petroselinum crispum and Rosmarinus officinalis against bacteria that cause urinary tract infections.	Petrolini FV, Lucarini R, de Souza MG, Pires RH, Cunha WR, Martins CH.	Braz J Microbiol	10.1590/s1517-83822013005000061	2013
Enzymology	A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and Panton-Valentine Leucocidin.	Al-Talib H, Yean CY, Al-Khateeb A, Hassan H, Singh KK, Al-Jashamy K, Ravichandran M.	BMC Microbiol	10.1186/1471-2180-9-113	2009
	Antimicrobial and antifungal properties of the essential oil and methanol extracts of Eucalyptus largiflorens and Eucalyptus intertexta.	Safaei-Ghomi J, Ahd AA.	Pharmacogn Mag	10.4103/0973-1296.66930	2010
	Volatile compounds analysis and antioxidant, antimicrobial and cytotoxic activities of Mindium laevigatum.	Ebrahimabadi AH, Movahedpour MM, Batooli H, Ebrahimabadi EH, Mazoochi A, Qamsari MM.	Iran J Basic Med Sci	10.22038/ijbms.2016.7921	2016
	Total phenolic, total flavonoids, antioxidant and antimicrobial activities of scrophularia striata boiss extracts.	Mahboubi M, Kazempour N, Boland Nazar AR.	Jundishapur J Nat Pharm Prod		2013
	Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production.	Shishparenok AN, Gladilina YA, Zhdanov DD.	Int J Mol Sci	10.3390/ijms242015220	2023
	Synthesis and spectrum of the neoglycoside ACHN-490.	Aggen JB, Armstrong ES, Goldblum AA, Dozzo P, Linsell MS, Gliedt MJ, Hildebrandt DJ, Feeney LA, Kubo A, Matias RD, Lopez S, Gomez M, Wlasichuk KB, Diokno R, Miller GH, Moser HE.	Antimicrob Agents Chemother	10.1128/aac.00572-10	2010
	Diversity, Novelty, and Antimicrobial Activity of Endophytic Actinobacteria From Mangrove Plants in Beilun Estuary National Nature Reserve of Guangxi, China.	Jiang ZK, Tuo L, Huang DL, Osterman IA, Tyurin AP, Liu SW, Lukyanov DA, Sergiev PV, Dontsova OA, Korshun VA, Li FN, Sun CH.	Front Microbiol	10.3389/fmicb.2018.00868	2018
	Characterisation and antimicrobial activity of biosurfactant extracts produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa isolated from a wastewater treatment plant.	Ndlovu T, Rautenbach M, Vosloo JA, Khan S, Khan W.	AMB Express	10.1186/s13568-017-0363-8	2017
	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Antimicrob Agents Chemother	10.1128/aac.02395-14	2014
Phylogeny	Antimicrobial potential of Actinomycetes species isolated from marine environment.	Valli S, Suvathi SS, Aysha OS, Nirmala P, Vinoth KP, Reena A.	Asian Pac J Trop Biomed	10.1016/s2221-1691(12)60078-1	2012
Pathogenicity	[Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials].	Corso A, Galas MF, Rossi MA.	Rev Argent Microbiol		1996
	Biological screening of araripe basin medicinal plants using Artemia salina Leach and pathogenic bacteria.	da Costa JG, Campos AR, Brito SA, Pereira CK, Souza EO, Rodrigues FF.	Pharmacogn Mag	10.4103/0973-1296.71792	2010
	Determination of antimicrobial effect, antioxidant activity and phenolic contents of desert truffle in Turkey.	Dogan HH, Aydin S.	Afr J Tradit Complement Altern Med	10.4314/ajtcam.v10i4.9	2013
Pathogenicity	Microbial growth and quorum sensing antagonist activities of herbal plants extracts.	Al-Hussaini R, Mahasneh AM.	Molecules	10.3390/molecules14093425	2009
Pathogenicity	Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins.	Cartelle M, del Mar Tomas M, Pertega S, Beceiro A, Dominguez MA, Velasco D, Molina F, Villanueva R, Bou G.	J Clin Microbiol	10.1128/jcm.42.9.4242-4249.2004	2004
Enzymology	Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.	Agudelo M, Rodriguez CA, Pelaez CA, Vesga O.	Antimicrob Agents Chemother	10.1128/aac.00350-13	2014
	Cytotoxicity and antimicrobial activity of marine macro algae (Dictyotaceae and Ulvaceae) from the Persian Gulf.	Mashjoor S, Yousefzadi M, Esmaeili MA, Rafiee R.	Cytotechnology	10.1007/s10616-015-9921-6	2016
	Synthesis of some nucleosides derivatives from L- rhamnose with expected biological activity.	Ghoneim AA.	Chem Cent J	10.1186/1752-153x-5-7	2011
Pathogenicity	Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin.	Rodriguez CA, Agudelo M, Zuluaga AF, Vesga O.	Antimicrob Agents Chemother	10.1128/aac.03633-14	2015
	Bacteriophages as Potential Tools for Detection and Control of Salmonella spp. in Food Systems.	Wei S, Chelliah R, Rubab M, Oh DH, Uddin MJ, Ahn J.	Microorganisms	10.3390/microorganisms7110570	2019
	Controlled expression in Klebsiella pneumoniae and Shigella flexneri using a bacteriophage P1-derived C1-regulated promoter system.	Schofield DA, Westwater C, Dolan JW, Schmidt MG, Norris JS.	J Bacteriol	10.1128/jb.183.23.6947-6950.2001	2001
	Synthesis, Biological Evaluation and Docking Studies of Benzoxazoles Derived from Thymoquinone.	Glamoclija U, Padhye S, Spirtovic-Halilovic S, Osmanovic A, Veljovic E, Roca S, Novakovic I, Mandic B, Turel I, Kljun J, Trifunovic S, Kahrovic E, Kraljevic Pavelic S, Harej A, Klobucar M, Zavrsnik D.	Molecules	10.3390/molecules23123297	2018
	Metal-based nanoparticles, sensors, and their multifaceted application in food packaging.	Kumar A, Choudhary A, Kaur H, Mehta S, Husen A.	J Nanobiotechnology	10.1186/s12951-021-00996-0	2021
	Chemical composition and antimicrobial activity of Satureja hortensis and Trachyspermum copticum essential oil.	Mahboubi M, Kazempour N.	Iran J Microbiol		2011
	Antibacterial, antioxidant, and anticholinesterase activities of plant seed extracts from Brazilian semiarid region.	Farias DF, Souza TM, Viana MP, Soares BM, Cunha AP, Vasconcelos IM, Ricardo NM, Ferreira PM, Melo VM, Carvalho AF.	Biomed Res Int	10.1155/2013/510736	2013
Metabolism	Pharmacokinetics of difloxacin and its concentration in body fluids and endometrial tissues of mares after repeated intragastric administration.	Adams AR, Haines GR, Brown MP, Gronwall R, Merritt K.	Can J Vet Res		2005
	A review on antibacterial, antiviral, and antifungal activity of curcumin.	Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K.	Biomed Res Int	10.1155/2014/186864	2014
	Functional insights into the Streptococcus pneumoniae HicBA toxin-antitoxin system based on a structural study.	Kim DH, Kang SM, Park SJ, Jin C, Yoon HJ, Lee BJ.	Nucleic Acids Res	10.1093/nar/gky469	2018
Enzymology	Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody.	Steinmetz I, Reganzerowski A, Brenneke B, Haussler S, Simpson A, White NJ.	J Clin Microbiol	10.1128/jcm.37.1.225-228.1999	1999
Pathogenicity	Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide.	Won HS, Kang SJ, Choi WS, Lee BJ.	Mol Cells	10.1007/s10059-011-0005-y	2011
	Ketolide treatment of Haemophilus influenzae experimental pneumonia.	Piper KE, Rouse MS, Steckelberg JM, Wilson WR, Patel R.	Antimicrob Agents Chemother	10.1128/aac.43.3.708	1999
Pathogenicity	[Bactericidal activity of amoxicillin and cefaclor in an "in vitro" kinetic model (author's transl)].	Pothier P, Kazmierczak A, Siebor E, Gaillard MC, Pechinot A.	Ann Microbiol (Paris)		1981
Metabolism	Molecular cloning and characterization of three beta-defensins from canine testes.	Sang Y, Ortega MT, Blecha F, Prakash O, Melgarejo T.	Infect Immun	10.1128/iai.73.5.2611-2620.2005	2005
Pathogenicity	In vitro antibacterial activity of concentrated polyethylene glycol 400 solutions.	Chirife J, Herszage L, Joseph A, Bozzini JP, Leardini N, Kohn ES.	Antimicrob Agents Chemother	10.1128/aac.24.3.409	1983
	Synthesis and antimicrobial activity of new 4-heteroarylamino coumarin derivatives containing nitrogen and sulfur as heteroatoms.	Dekic BR, Radulovic NS, Dekic VS, Vukicevic RD, Palic RM.	Molecules	10.3390/molecules15042246	2010
Enzymology	Rapid detection of enterohemorrhagic Escherichia coli by real-time PCR with fluorescent hybridization probes.	Bellin T, Pulz M, Matussek A, Hempen HG, Gunzer F.	J Clin Microbiol	10.1128/jcm.39.1.370-374.2001	2001
	The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection.	Brogden KA, Kalfa VC, Ackermann MR, Palmquist DE, McCray PB, Tack BF.	Antimicrob Agents Chemother	10.1128/aac.45.1.331-334.2001	2001
	Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.	Piper KE, Rouse MS, Ronningen KL, Steckelberg JM, Wilson WR, Patel R.	Antimicrob Agents Chemother	10.1128/aac.44.9.2554-2556.2000	2000
	Retain intermittent dosing of carbapenems.	Hanberger H, Nilsson LE.	Antimicrob Agents Chemother	10.1128/aac.38.1.159	1994
Pathogenicity	N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers.	Juhas M, Kucerova L, Horacek O, Jandourek O, Kubicek V, Konecna K, Kucera R, Barta P, Janousek J, Paterova P, Kunes J, Dolezal M, Zitko J.	Molecules	10.3390/molecules25071518	2020
Pathogenicity	Ultrastructure and viability of K. pneumoniae treated with fosfomycin.	Schmid EN.	Zentralbl Bakteriol A	10.1016/s0172-5599(80)80038-1	1980
Phylogeny	PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis.	Nagai H, Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M.	J Clin Microbiol	10.1128/jcm.37.3.694-699.1999	1999
	Ethnobotanical and antimicrobial study of some selected medicinal plants used in Khyber Pakhtunkhwa (KPK) as a potential source to cure infectious diseases.	Khan N, Abbasi AM, Dastagir G, Nazir A, Shah GM, Shah MM, Shah MH.	BMC Complement Altern Med	10.1186/1472-6882-14-122	2014
	Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens.	Tomas JM, Camprubi S, Merino S, Davey MR, Williams P.	Infect Immun	10.1128/iai.59.6.2006-2011.1991	1991
	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Molecules	10.3390/molecules18010859	2013
	Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays.	Devleeschouwer MJ, Cornil MF, Dony J.	Appl Environ Microbiol	10.1128/aem.50.6.1509-1511.1985	1985
	Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.	Simon A, Kullberg BJ, Tripet B, Boerman OC, Zeeuwen P, van der Ven-Jongekrijg J, Verweij P, Schalkwijk J, Hodges R, van der Meer JW, Netea MG.	Antimicrob Agents Chemother	10.1128/aac.00155-07	2008
	Structure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfish.	Cantisani M, Leone M, Mignogna E, Kampanaraki K, Falanga A, Morelli G, Galdiero M, Galdiero S.	Antimicrob Agents Chemother	10.1128/aac.01341-13	2013
Pathogenicity	A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota.	Wang M, Firrman J, Liu L, Yam K.	Biomed Res Int	10.1155/2019/7010467	2019
Phylogeny	Rapid-cycle PCR and fluorimetry for detection of mycobacteria.	Lachnik J, Ackermann B, Bohrssen A, Maass S, Diephaus C, Puncken A, Stermann M, Bange FC.	J Clin Microbiol	10.1128/jcm.40.9.3364-3373.2002	2002
	Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.	Anguita-Alonso P, Rouse MS, Piper KE, Steckelberg JM, Patel R.	Antimicrob Agents Chemother	10.1128/aac.50.4.1263-1267.2006	2006
Enzymology	Use of an oligonucleotide probe to detect Vibrio parahaemolyticus in artificially contaminated oysters.	Lee C, Chen LH, Liu ML, Su YC.	Appl Environ Microbiol	10.1128/aem.58.10.3419-3422.1992	1992
	Electrophoretic transfer from polyacrylamide gel to nitrocellulose sheets, a new method to characterize multilocus enzyme genotypes of Klebsiella strains.	Combe ML, Pons JL, Sesboue R, Martin JP.	Appl Environ Microbiol	10.1128/aem.60.1.26-30.1994	1994
	Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial.	Brogden KA, Ackermann M, Huttner KM.	Antimicrob Agents Chemother	10.1128/aac.41.7.1615	1997
Pathogenicity	Branched Peptide, B2088, Disrupts the Supramolecular Organization of Lipopolysaccharides and Sensitizes the Gram-negative Bacteria.	Lakshminarayanan R, Tan WX, Aung TT, Goh ET, Muruganantham N, Li J, Chang JY, Dikshit N, Saraswathi P, Lim RR, Kang TS, Balamuralidhar V, Sukumaran B, Verma CS, Sivaraman J, Chaurasia SS, Liu S, Beuerman RW.	Sci Rep	10.1038/srep25905	2016
Enzymology	Penetration of ciprofloxacin and fleroxacin into biliary tract.	Edmiston CE, Suarez EC, Walker AP, Demeure MP, Frantzides CT, Schulte WJ, Wilson SD.	Antimicrob Agents Chemother	10.1128/aac.40.3.787	1996
Pathogenicity	Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.	Klepser ME, Ernst EJ, Petzold CR, Rhomberg P, Doern GV.	Antimicrob Agents Chemother	10.1128/aac.45.3.673-678.2001	2001
Enzymology	Towards a pathogenic Escherichia coli detection platform using multiplex SYBR®Green Real-time PCR methods and high resolution melting analysis.	Kagkli DM, Folloni S, Barbau-Piednoir E, Van den Eede G, Van den Bulcke M.	PLoS One	10.1371/journal.pone.0039287	2012
Enzymology	First case of type E wound botulism diagnosed using real-time PCR.	Artin I, Bjorkman P, Cronqvist J, Radstrom P, Holst E.	J Clin Microbiol	10.1128/jcm.01192-07	2007
	Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients.	Nilsson HO, Stenram U, Ihse I, Wadstrom T.	World J Gastroenterol	10.3748/wjg.v12.i19.3038	2006
Pathogenicity	Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative.	Drews J, Georgopoulos A, Laber G, Schutze E, Unger J.	Antimicrob Agents Chemother	10.1128/aac.7.5.507	1975
Phylogeny	Application of the modular approach to an in-house validation study of real-time PCR methods for the detection and serogroup determination of verocytotoxigenic Escherichia coli.	Kagkli DM, Weber TP, Van den Bulcke M, Folloni S, Tozzoli R, Morabito S, Ermolli M, Gribaldo L, Van den Eede G.	Appl Environ Microbiol	10.1128/aem.05357-11	2011
Pathogenicity	IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.	Mosca DA, Hurst MA, So W, Viajar BS, Fujii CA, Falla TJ.	Antimicrob Agents Chemother	10.1128/aac.44.7.1803-1808.2000	2000
Metabolism	Enoxacin penetration into human prostatic tissue.	Bergeron MG, Roy R, Lessard C, Foucault P.	Antimicrob Agents Chemother	10.1128/aac.32.9.1433	1988
Pathogenicity	In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.	Okamoto S, Hamana Y, Inoue M, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.31.7.1111	1987
Pathogenicity	Ovine pulmonary surfactant induces killing of Pasteurella haemolytica, Escherichia coli, and Klebsiella pneumoniae by normal serum.	Brogden KA.	Infect Immun	10.1128/iai.60.12.5182-5189.1992	1992
Pathogenicity	Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation.	Gollapudi SV, Prabhala RH, Thadepalli H.	Antimicrob Agents Chemother	10.1128/aac.29.2.337	1986
Pathogenicity	In vitro study of bacterial growth inhibition in concentrated sugar solutions: microbiological basis for the use of sugar in treating infected wounds.	Chirife J, Herszage L, Joseph A, Kohn ES.	Antimicrob Agents Chemother	10.1128/aac.23.5.766	1983
Pathogenicity	Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.	Weinberg E, Shungu DL, Gadebusch HH.	J Clin Microbiol	10.1128/jcm.19.2.207-209.1984	1984
	Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations.	Hershberger E, Coyle EA, Kaatz GW, Zervos MJ, Rybak MJ.	Antimicrob Agents Chemother	10.1128/aac.44.7.1921-1924.2000	2000
Pathogenicity	Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.	Takahata M, Yamada H, Morita T, Furubou S, Minami S, Todo Y, Watanabe Y, Narita H.	Antimicrob Agents Chemother	10.1128/aac.46.6.1760-1765.2002	2002
	Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.	Drobot GR, Karlowsky JA, Hoban DJ, Zhanel GG.	Antimicrob Agents Chemother	10.1128/aac.40.1.237	1996
Pathogenicity	Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives.	Kibwage IO, Hoogmartens J, Roets E, Vanderhaeghe H, Verbist L, Dubost M, Pascal C, Petitjean P, Levol G.	Antimicrob Agents Chemother	10.1128/aac.28.5.630	1985
	Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.	Brogden KA, De Lucca AJ, Bland J, Elliott S.	Proc Natl Acad Sci U S A	10.1073/pnas.93.1.412	1996
Metabolism	Norfloxacin penetration into human renal and prostatic tissues.	Bergeron MG, Thabet M, Roy R, Lessard C, Foucault P.	Antimicrob Agents Chemother	10.1128/aac.28.2.349	1985
Pathogenicity	Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.	Aeschlimann JR, Hershberger E, Rybak MJ.	Antimicrob Agents Chemother	10.1128/aac.44.5.1153-1158.2000	2000
Pathogenicity	Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.	Hershberger E, Rybak MJ.	Antimicrob Agents Chemother	10.1128/aac.44.3.598-601.2000	2000
Metabolism	Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo.	Rylander M, Norrby SR.	Antimicrob Agents Chemother	10.1128/aac.23.3.352	1983
	Comparative efficacy of ciprofloxacin and ceftriaxone in experimental arthritis caused by Escherichia coli.	Bayer AS, Norman DC, Blomquist IK.	Antimicrob Agents Chemother	10.1128/aac.30.1.184	1986
Pathogenicity	Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.	Coyle EA, Kaatz GW, Rybak MJ.	Antimicrob Agents Chemother	10.1128/aac.45.6.1654-1659.2001	2001
Pathogenicity	Activity of temafloxacin against respiratory pathogens.	Swanson RN, Hardy DJ, Chu DT, Shipkowitz NL, Clement JJ.	Antimicrob Agents Chemother	10.1128/aac.35.3.423	1991
	Complexing of bacterial lipopolysaccharide with lung surfactant.	Brogden KA, Cutlip RC, Lehmkuhl HD.	Infect Immun	10.1128/iai.52.3.644-649.1986	1986
Metabolism	Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function.	Gasser TC, Ebert SC, Graversen PH, Madsen PO.	Antimicrob Agents Chemother	10.1128/aac.31.5.709	1987
	Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.	Lubowski TJ, Nightingale C, Sweeney K, Quintiliani R, Zhi J.	Antimicrob Agents Chemother	10.1128/aac.36.3.651	1992
Enzymology	Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function.	Tam VH, McKinnon PS, Akins RL, Drusano GL, Rybak MJ.	Antimicrob Agents Chemother	10.1128/aac.47.6.1853-1861.2003	2003
	Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.	Kasanah N, Hamann MT.	Curr Opin Investig Drugs		2004
	Improved susceptibility disk assay method employing an agar overlay technique.	Anderson B.	Antimicrob Agents Chemother	10.1128/aac.14.5.761	1978
	PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis.	Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M.	J Clin Microbiol	10.1128/jcm.34.10.2464-2468.1996	1996
	Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.	Frimodt-Moller PC, Jensen KM, Madsen PO.	Antimicrob Agents Chemother	10.1128/aac.24.4.560	1983
Pathogenicity	Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.	Palmer SM, Rybak MJ.	Antimicrob Agents Chemother	10.1128/aac.40.3.701	1996
	High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.	Auten GM, Preheim LC, Sookpranee M, Bittner MJ, Sookpranee T, Vibhagool A.	Antimicrob Agents Chemother	10.1128/aac.35.12.2558	1991
	Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.	Brumfitt W, Franklin I, Grady D, Hamilton-Miller JM, Iliffe A.	Antimicrob Agents Chemother	10.1128/aac.26.5.757	1984
Enzymology	General primer-mediated PCR for detection of Aspergillus species.	Melchers WJ, Verweij PE, van den Hurk P, van Belkum A, De Pauw BE, Hoogkamp-Korstanje JA, Meis JF.	J Clin Microbiol	10.1128/jcm.32.7.1710-1717.1994	1994
	Endophytic fungi: a reservoir of antibacterials.	Deshmukh SK, Verekar SA, Bhave SV.	Front Microbiol	10.3389/fmicb.2014.00715	2014
Metabolism	beta-cyanoalanine production by marine bacteria on cyanide-free medium and its specific inhibitory activity toward cyanobacteria.	Yoshikawa K, Adachi K, Nishijima M, Takadera T, Tamaki S, Harada K, Mochida K, Sano H.	Appl Environ Microbiol	10.1128/aem.66.2.718-722.2000	2000
	Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.	Ostergaard C, Sorensen TK, Knudsen JD, Frimodt-Moller N.	Antimicrob Agents Chemother	10.1128/aac.42.7.1706	1998
Metabolism	Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits.	Barriere SL, Kaatz GW, Schaberg DR, Fekety R.	Antimicrob Agents Chemother	10.1128/aac.31.7.1075	1987
	In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.	Fernandez-Guerrero M, Rouse MS, Henry NK, Geraci JE, Wilson WR.	Antimicrob Agents Chemother	10.1128/aac.31.3.430	1987
Enzymology	Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.	Golper TA, Hartstein AI, Morthland VH, Christensen JM.	Antimicrob Agents Chemother	10.1128/aac.31.11.1787	1987
	The second international reference preparation of lymecycline.	Lightbown JW, Thomas AH, Berryman IL.	Bull World Health Organ		1973
Pathogenicity	Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.	Kaatz GW, Seo SM, Ruble CA.	Antimicrob Agents Chemother	10.1128/aac.37.5.1086	1993
	Comparative study of responses to neomycins B and C by microbiological and gas-liquid chromatographic assay methods.	Tsuji K, Robertson JH, Baas R, McInnis DJ.	Appl Microbiol	10.1128/am.18.3.396-398.1969	1969
Pathogenicity	Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.	Foster JK, Lentino JR, Strodtman R, DiVincenzo C.	Antimicrob Agents Chemother	10.1128/aac.30.6.823	1986
Enzymology	Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally.	Bitar N, Claes R, Van der Auwera P.	Antimicrob Agents Chemother	10.1128/aac.33.10.1686	1989
	Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.	Bayer AS, Lindsay P, Yih J, Hirano L, Lee D, Blomquist IK.	Antimicrob Agents Chemother	10.1128/aac.30.4.528	1986
	Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.	Kernodle DS, Kaiser AB.	Antimicrob Agents Chemother	10.1128/aac.38.6.1325	1994
Enzymology	Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei.	Steinmetz I, Rohde M, Brenneke B.	Infect Immun	10.1128/iai.63.10.3959-3965.1995	1995
Metabolism	Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain.	Omura S, Ikeda H, Malpartida F, Kieser HM, Hopwood DA.	Antimicrob Agents Chemother	10.1128/aac.29.1.13	1986
Enzymology	Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.	Araki H, Minami S, Watanabe Y, Yasuda T.	Antimicrob Agents Chemother	10.1128/aac.35.6.1131	1991
Metabolism	Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.	Gonzalez MA, Moranchel AH, Duran S, Pichardo A, Magana JL, Painter B, Forrest A, Drusano GL.	Antimicrob Agents Chemother	10.1128/aac.28.2.235	1985
Metabolism	Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin.	Fujii N, Yamashita Y, Arima Y, Nagashima M, Nakano H.	Antimicrob Agents Chemother	10.1128/aac.36.12.2589	1992
Metabolism	Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.	Gonzalez MA, Uribe F, Moisen SD, Fuster AP, Selen A, Welling PG, Painter B.	Antimicrob Agents Chemother	10.1128/aac.26.5.741	1984
	Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.	Schiff JB, Small GJ, Pennington JE.	Antimicrob Agents Chemother	10.1128/aac.26.1.1	1984
Pathogenicity	Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.	Masecar BL, Celesk RA, Robillard NJ.	Antimicrob Agents Chemother	10.1128/aac.34.2.281	1990
Pathogenicity	Studies on the mode of action of novobiocin.	BROCK TD.	J Bacteriol	10.1128/jb.72.3.320-323.1956	1956
Pathogenicity	Role of proline, cysteine and a disulphide bridge in the structure and activity of the anti-microbial peptide gaegurin 5.	Park SH, Kim HE, Kim CM, Yun HJ, Choi EC, Lee BJ.	Biochem J	10.1042/bj20020385	2002
Enzymology	Rapid microbial detection and enumeration using gel microdroplets and colorimetric or fluorescence indicator systems.	Williams GB, Weaver JC, Demain AL.	J Clin Microbiol	10.1128/jcm.28.5.1002-1008.1990	1990
Pathogenicity	Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.	Bamberger DM, Fields MT, Herndon BL.	Antimicrob Agents Chemother	10.1128/aac.35.11.2335	1991
	High-pressure liquid chromatography analysis of antibiotic susceptibility disks.	Hagel RB, Waysek EH, Cort WM.	Antimicrob Agents Chemother	10.1128/aac.16.3.372	1979
	Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids.	Zweerink MM, Edison A.	Antimicrob Agents Chemother	10.1128/aac.29.4.598	1986
Metabolism	Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.	Tartaglione TA, Raffalovich AC, Poynor WJ, Espinel-Ingroff A, Kerkering TM.	Antimicrob Agents Chemother	10.1128/aac.29.1.62	1986
	Investigations on the specificity of the Limulus test for the detection of endotoxin.	Wildfeuer A, Heymer B, Schleifer KH, Haferkamp O.	Appl Microbiol	10.1128/am.28.5.867-871.1974	1974
	Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.	Strunk RW, Gratz JC, Maserati R, Scheld WM.	Antimicrob Agents Chemother	10.1128/aac.28.3.428	1985
Metabolism	LL-A491, a monazomycin-like antibiotic.	Mitscher LA, Shay AJ, Bohonos N.	Appl Microbiol	10.1128/am.15.5.1002-1005.1967	1967
Metabolism	Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.	Celesk RA, Robillard NJ.	Antimicrob Agents Chemother	10.1128/aac.33.11.1921	1989
	The second international reference preparation of viomycin.	Lightbown JW, Bond JM, Skegg JL.	Bull World Health Organ		1973
	Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.	Kemmerich B, Small GJ, Pennington JE.	Antimicrob Agents Chemother	10.1128/aac.29.3.395	1986
	Serological study of trichloroacetic acid extracts of Bacteroides fragilis.	Abshire RL, Dowell VR, Lombard GL.	J Clin Microbiol	10.1128/jcm.9.2.274-279.1979	1979
	Open, prospective study of the clinical efficacy of ciprofloxacin.	Ramirez CA, Bran JL, Mejia CR, Garcia JF.	Antimicrob Agents Chemother	10.1128/aac.28.1.128	1985
	Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.	Bogard WC, Dunn DL, Abernethy K, Kilgarriff C, Kung PC.	Infect Immun	10.1128/iai.55.4.899-908.1987	1987
	Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.	Perronne CM, Malinverni R, Glauser MP.	Antimicrob Agents Chemother	10.1128/aac.31.4.539	1987
	Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.	Drusano GL, Johnson DE, Rosen M, Standiford HC.	Antimicrob Agents Chemother	10.1128/aac.37.3.483	1993
	Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.	Hardy DJ, Swanson RN, Hensey DM, Ramer NR, Bower RR, Hanson CW, Chu DT, Fernandes PB.	Antimicrob Agents Chemother	10.1128/aac.31.11.1768	1987
Enzymology	Preparation of four new antibiotics from a mutant of Streptomyces fradiae.	Shier WT, Rinehart KL, Gottlieb D.	Proc Natl Acad Sci U S A	10.1073/pnas.63.1.198	1969
Pathogenicity	A correlation between the structure of neomycin B and its action on bacteria.	SEBEK OK.	J Bacteriol	10.1128/jb.75.2.199-204.1958	1958
Pathogenicity	Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.	Hallander HO, Dornbusch K, Gezelius L, Jacobson K, Karlsson I.	Antimicrob Agents Chemother	10.1128/aac.22.5.743	1982
	Steroids. 159. Antimicrobial properties of 21,21-dimethoxy progesterone and other progesterone analogues.	CASAS-CAMPILLO C, BALANDRANO D, GALARZA A.	J Bacteriol	10.1128/jb.81.3.366-375.1961	1961
	Insects as hosts for mutualistic bacteria.	Feldhaar H, Gross R.	Int J Med Microbiol	10.1016/j.ijmm.2008.05.010	2009
	Differential Immune-Modulating Activities of Cell Walls and Secreted Metabolites from Probiotic Bacillus coagulans JBI-YZ6.3 under Normal versus Inflamed Culture Conditions.	Iloba I, McGarry SV, Yu L, Cruickshank D, Jensen GS.	Microorganisms	10.3390/microorganisms11102564	2023
	Potential Use of Bacillus coagulans in the Food Industry.	Konuray G, Erginkaya Z.	Foods	10.3390/foods7060092	2018
	Convergent evolution of antibiotic resistance mechanisms between pyrrolobenzodiazepines and albicidin in multidrug resistant Klebsiella pneumoniae.	Surani YM, Wand ME, Picconi P, Di Palma M, Zenezini Chiozzi R, Hasan MM, Andriollo P, Gratz S, Nahar KS, Maynard-Smith M, Sussmuth RD, Steiner RA, Rahman KM, Hind CK, Sutton JM.	NPJ Antimicrob Resist	10.1038/s44259-025-00104-4	2025
	Contribution of the efflux pump AcrAB-TolC to the tolerance of chlorhexidine and other biocides in Klebsiella spp.	Wand ME, Darby EM, Blair JMA, Sutton JM.	J Med Microbiol	10.1099/jmm.0.001496	2022
	Ionic Liquid-Based Materials for Biomedical Applications.	Correia DM, Fernandes LC, Fernandes MM, Hermenegildo B, Meira RM, Ribeiro C, Ribeiro S, Reguera J, Lanceros-Mendez S.	Nanomaterials (Basel)	10.3390/nano11092401	2021
	The Second International Standard for streptomycin.	HUMPHREY JH, LIGHTBOWN JW, MUSSETT MV.	Bull World Health Organ		1959
	Efficient Absorbance-Based Assay for Rapid Antibiotic Susceptibility Testing of Enterobacterales.	Axelsson C, Nilson B, Rehnstam-Holm AS.	Antibiotics (Basel)	10.3390/antibiotics13090852	2024
	Diverse and abundant phages exploit conjugative plasmids.	Quinones-Olvera N, Owen SV, McCully LM, Marin MG, Rand EA, Fan AC, Martins Dosumu OJ, Paul K, Sanchez Castano CE, Petherbridge R, Paull JS, Baym M.	Nat Commun	10.1038/s41467-024-47416-z	2024
	Antimicrobial Activity of Green Silver Nanoparticles Synthesized by Different Extracts from the Leaves of Saudi Palm Tree (Phoenix Dactylifera L.).	Al Mutairi JF, Al-Otibi F, Alhajri HM, Alharbi RI, Alarifi S, Alterary SS.	Molecules	10.3390/molecules27103113	2022
	Pharmaceutical Potential of Synthetic and Natural Pyrrolomycins.	Cascioferro S, Raimondi MV, Cusimano MG, Raffa D, Maggio B, Daidone G, Schillaci D.	Molecules	10.3390/molecules201219797	2015
	In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.	Hikida M, Itahashi K, Igarashi A, Shiba T, Kitamura M.	Antimicrob Agents Chemother	10.1128/aac.43.8.2010	1999
Pathogenicity	In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.	Toda M, Arao N, Nohara C, Susaki K, Tachibana A.	Antimicrob Agents Chemother	10.1128/aac.27.4.565	1985
Pathogenicity	In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin.	Tamura A, Okamoto R, Yoshida T, Yamamoto H, Kondo S, Inoue M, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.32.9.1421	1988
Pathogenicity	In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.	Katsu K, Kitoh K, Inoue M, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.22.2.181	1982
Pathogenicity	Development of an antivirulence drug against Streptococcus mutans: repression of biofilm formation, acid tolerance, and competence by a histidine kinase inhibitor, walkmycin C.	Eguchi Y, Kubo N, Matsunaga H, Igarashi M, Utsumi R.	Antimicrob Agents Chemother	10.1128/aac.01646-10	2011
Pathogenicity	In vitro and in vivo antibacterial activities of MT-141, a new semisynthetic cephamycin, compared with those of five cephalosporins.	Inouye S, Goi H, Watanabe T, Hara T, Miyauchi K, Yoshida T, Kazuno Y, Kadosawa H, Hirano F, Kawaharajo K.	Antimicrob Agents Chemother	10.1128/aac.26.5.722	1984
Pathogenicity	Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.	Kato M, Inoue M, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.22.5.721	1982
Pathogenicity	In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.	Utsui Y, Inoue M, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.31.7.1085	1987
Pathogenicity	Cefroxadine (CGP-9000), an orally active cephalosporin.	Yasuda K, Kurashige S, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.18.1.105	1980
Pathogenicity	PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation.	Noguchi H, Eda Y, Tobiki H, Nakagome T, Komatsu T.	Antimicrob Agents Chemother	10.1128/aac.9.2.262	1976
Pathogenicity	In vitro antibacterial activity of AM-715, a new nalidixic acid analog.	Ito A, Hirai K, Inoue M, Koga H, Suzue S, Irikura T, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.17.2.103	1980
Metabolism	New antibacterial agent (U-24,544) isolated from Streptomyces griseus.	Herr RR, Reusser F.	Appl Microbiol	10.1128/am.15.5.1142-1144.1967	1967
Pathogenicity	Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.	Kobayashi F, Saino Y, Koshi T, Hattori Y, Nakayama M, Iwasaki A, Mori T, Mitsuhashi S.	Antimicrob Agents Chemother	10.1128/aac.21.4.536	1982
	New Selective Growth Inhibitors of Sphaerotilus natans, Anslimins A and B.	Takiguchi Y, Yoshikawa H, Terao M.	Appl Environ Microbiol	10.1128/aem.39.6.1123-1128.1980	1980
	Selective Growth Inhibition of Sphaerotilus natans and Beggiatoa sp. by Nucleosides.	Takiguchi Y, Yoshikawa H, Terao M.	Appl Environ Microbiol	10.1128/aem.36.5.658-661.1978	1978
Pathogenicity	4,4'-isopropylidine-bis(2-isopropyl)phenol, a new inhibitor for cell wall formation of Bacillus subtilis.	Shimi IR, Shoukry S, Zaki Z.	Antimicrob Agents Chemother	10.1128/aac.9.4.580	1976
	AN ANTIPHAGE AGENT ISOLATED FROM ASPERGILLUS SP.	Hanson FR, Eble TE.	J Bacteriol	10.1128/jb.58.4.527-529.1949	1949
	The antimicrobial properties of some alpha-amino-oxy-acids, alpha-amino-oxy-hydrazides, alkoxyamines, alkoxydiguanides and their derivatives.	PRICE SA, MAMALIS P, McHALE D, GREEN J.	Br J Pharmacol Chemother	10.1111/j.1476-5381.1960.tb01238.x	1960
Metabolism	The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis.	Omura S.	Bacteriol Rev	10.1128/br.40.3.681-697.1976	1976
Pathogenicity	Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.	Young LS, Hewitt WL.	Antimicrob Agents Chemother	10.1128/aac.4.6.617	1973
	Synthesis and Antimicrobial Activity of Newly Synthesized Nicotinamides.	Markovic BA, Marinkovic A, Stankovic JA, Mijatovic S, Cvijetic I, Simic M, Arandjelovic I.	Pharmaceutics	10.3390/pharmaceutics16081084	2024
	Antimicrobial Activities of Essential Oils of Different Pinus Species from Bosnia and Herzegovina.	Mirkovic S, Tadic V, Milenkovic MT, Usjak D, Racic G, Bojovic D, Zugic A.	Pharmaceutics	10.3390/pharmaceutics16101331	2024
	Antioxidant, Enzyme-Inhibitory and Antimicrobial Activity of Underutilized Wheat and Maize Crop Residues.	Samardzic S, Velickovic I, Milenkovic MT, Arsenijevic J, Medarevic D, Maksimovic Z.	Plants (Basel)	10.3390/plants14030346	2025
	A Review of the Antibacterial, Fungicidal and Antiviral Properties of Selenium Nanoparticles.	Serov DA, Khabatova VV, Vodeneev V, Li R, Gudkov SV.	Materials (Basel)	10.3390/ma16155363	2023
	Comparative Study of the Antimicrobial Activity of Selenium Nanoparticles With Different Surface Chemistry and Structure.	Filipovic N, Usjak D, Milenkovic MT, Zheng K, Liverani L, Boccaccini AR, Stevanovic MM.	Front Bioeng Biotechnol	10.3389/fbioe.2020.624621	2020
	Hypericum Essential Oils-Composition and Bioactivities: An Update (2012-2022).	Grafakou ME, Barda C, Karikas GA, Skaltsa H.	Molecules	10.3390/molecules27165246	2022
	Isolation of antimicrobial producing Actinobacteria from soil samples.	Elbendary AA, Hessain AM, El-Hariri MD, Seida AA, Moussa IM, Mubarak AS, Kabli SA, Hemeg HA, El Jakee JK.	Saudi J Biol Sci	10.1016/j.sjbs.2017.05.003	2018
	Composition and antimicrobial activity of Marrubium incanum Desr. (Lamiaceae) essential oil.	Petrovic S, Pavlovic M, Maksimovic Z, Milenkovic M, Couladis M, Tzakouc O, Niketic M.	Nat Prod Commun	10.1177/1934578x0900400324	2009
Metabolism	The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection.	Bleriot I, Blasco L, Pacios O, Fernandez-Garcia L, Ambroa A, Lopez M, Ortiz-Cartagena C, Cuenca FF, Oteo-Iglesias J, Pascual A, Martinez-Martinez L, Domingo-Calap P, Wood TK, Tomas M	Sci Rep	10.1038/s41598-022-08111-5	2022
Enzymology	Capillary Zone Electrophoresis in Tandem with Flow Cytometry in Viability Study of Various ATCC Bacterial Strains under Antibiotic Treatment.	Kupczyk W, Maslak E, Railean-Plugaru V, Pomastowski P, Jackowski M, Buszewski B	Int J Environ Res Public Health	10.3390/ijerph19031833	2022
Phylogeny	Potential of a Bacteriophage Isolated from Wastewater in Treatment of Lobar Pneumonia Infection Induced by Klebsiella pneumoniae in Mice.	Soleimani Sasani M, Eftekhar F	Curr Microbiol	10.1007/s00284-020-02041-z	2020
	Allium ursinum and Allium oschaninii against Klebsiella pneumoniae and Candida albicans Mono- and Polymicrobic Biofilms in In Vitro Static and Dynamic Models.	Galdiero E, Di Onofrio V, Maione A, Gambino E, Gesuele R, Menale B, Ciaravolo M, Carraturo F, Guida M	Microorganisms	10.3390/microorganisms8030336	2020
Pathogenicity	N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.	Asadipour A, Moshafi MH, Khosravani L, Moghimi S, Amou E, Firoozpour L, Ilbeigi G, Beiki K, Soleimani E, Foroumadi A	Daru	10.1007/s40199-018-0226-0	2018
Pathogenicity	Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa.	Holfeld L, Knappe D, Hoffmann R	J Antimicrob Chemother	10.1093/jac/dkx482	2018
Pathogenicity	An integrated study on antimicrobial activity and ecotoxicity of quantum dots and quantum dots coated with the antimicrobial peptide indolicidin.	Galdiero E, Siciliano A, Maselli V, Gesuele R, Guida M, Fulgione D, Galdiero S, Lombardi L, Falanga A	Int J Nanomedicine	10.2147/IJN.S107752	2016
Pathogenicity	Gradual increase in antibiotic concentration affects persistence of Klebsiella pneumoniae.	Ren H, He X, Zou X, Wang G, Li S, Wu Y	J Antimicrob Chemother	10.1093/jac/dkv251	2015
Pathogenicity	Characterization of MATE-type multidrug efflux pumps from Klebsiella pneumoniae MGH78578.	Ogawa W, Minato Y, Dodan H, Onishi M, Tsuchiya T, Kuroda T	PLoS One	10.1371/journal.pone.0121619	2015
Pathogenicity	Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.	Agudelo M, Rodriguez CA, Zuluaga AF, Vesga O	Int J Antimicrob Agents	10.1016/j.ijantimicag.2014.10.014	2014
Pathogenicity	Suppression of stop codon UGA in acrB can contribute to antibiotic resistance in Klebsiella pneumoniae ATCC10031.	Onishi M, Mizusawa M, Tsuchiya T, Kuroda T, Ogawa W	Gene	S0378-1119(13)01424-8	2014
Metabolism	Virulence of Klebsiella pneumoniae isolates harboring bla KPC-2 carbapenemase gene in a Caenorhabditis elegans model.	Lavigne JP, Cuzon G, Combescure C, Bourg G, Sotto A, Nordmann P	PLoS One	10.1371/journal.pone.0067847	2013
	Silver-embedded modified hyperbranched epoxy/clay nanocomposites as antibacterial materials.	Roy B, Bharali P, Konwar BK, Karak N	Bioresour Technol	10.1016/j.biortech.2012.09.129	2012
Pathogenicity	Chemical composition and antimicrobial activity of the essential oil of Linum pubescens growing wild in Jordan.	Al-Qudah MA	Nat Prod Res	10.1080/14786419.2012.715291	2012
Metabolism	Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae.	Ogawa W, Onishi M, Ni R, Tsuchiya T, Kuroda T	Gene	10.1016/j.gene.2012.02.008	2012
Pathogenicity	Preliminary investigation of a mice model of Klebsiella pneumoniae subsp. ozaenae induced pneumonia.	Renois F, Jacques J, Guillard T, Moret H, Pluot M, Andreoletti L, de Champs C	Microbes Infect	10.1016/j.micinf.2011.05.013	2011
Phylogeny	Evaluation of the antibacterial activity of the methylene chloride extract of Miconia ligustroides, isolated triterpene acids, and ursolic acid derivatives.	Cunha WR, de Matos GX, Souza MG, Tozatti MG, Andrade e Silva ML, Martins CH, da Silva R, Da Silva Filho AA	Pharm Biol	10.3109/13880200903062648	2010
Pathogenicity	Properties and expression of a multidrug efflux pump AcrAB-KocC from Klebsiella pneumoniae.	Li DW, Onishi M, Kishino T, Matsuo T, Ogawa W, Kuroda T, Tsuchiya T	Biol Pharm Bull	10.1248/bpb.31.577	2008
Enzymology	Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats.	Albarellos GA, Montoya L, Landoni MF	Vet J	10.1016/j.tvjl.2004.05.011	2005
Enzymology	Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.	Albarellos GA, Ambros LA, Landoni MF	J Vet Pharmacol Ther	10.1111/j.1365-2885.2005.00669.x	2005
Enzymology	Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.	Albarellos GA, Kreil VE, Landoni MF	J Vet Pharmacol Ther	10.1111/j.1365-2885.2004.00573.x	2004
Pathogenicity	Clinically significant borderline resistance of sequential clinical isolates of Klebsiella pneumoniae.	Wagenlehner FM, Heisig P, Irtenkauf C, Notka F, Decker J, Lehn N, Linde H	Int J Antimicrob Agents	10.1016/s0924-8579(03)00126-2	2003
Pathogenicity	Antibacterial activity of gentamicin and ciprofloxacin against Gram-negative bacteria: interactions with pig and calf sera.	Miglioli PA, Silini R, Carzeri O, Grabocka E, Allerberger F	Pharmacol Res	10.1006/phrs.1998.0447	1999
	Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor.	Engel LS, Callegan MC, Hill JM, O'Callaghan RJ	J Ocul Pharmacol	10.1089/jop.1993.9.311	1993
Pathogenicity	[Clinical studies on cefteram pivoxil granules in pediatrics].	Sato H, Narita A, Nakazawa S, Suzuki H, Matsumoto K, Nakanishi Y, Niino K, Nakazawa S	Jpn J Antibiot		1989
Pathogenicity	[Determination of the bactericidal potency of cefatrizine and other oral antibiotics against Haemophilus influenzae, Klebsiella pneumoniae and Streptococcus pyogenes].	Carlone NA, Cuffini AM, Tullio V, Barone R	G Batteriol Virol Immunol		1986
Pathogenicity	Bioassay procedures for norfloxacin.	Bland J, Edison A, Huber J	Eur J Clin Microbiol	10.1007/BF02029527	1983
	Semisynthesis, in silico study and in vitro antibacterial evaluation of fucosterol derivatives.	da Silva FEF, Avila FDN, Pereira NMO, de Freitas MD, Pessoa ODL, da Fonseca AM, da Costa JGM, Santiago GMP	Steroids	10.1016/j.steroids.2022.109137	2022
	Immunogenic Evaluation of MPEG-PCL & PLGA Nanoparticles Containing Klebsiella pneumoniae K2O1 Capsular Antigen in Pulmonary Infection Model of Mice.	Ghaderinia P, Shapouri R, Rostamizadeh K, Khodavandi A, Mahdavi M	IEEE Trans Nanobioscience	10.1109/TNB.2022.3195483	2022
Pathogenicity	Azithromycin possesses biofilm-inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia.	Moshynets OV, Baranovskyi TP, Cameron S, Iungin OS, Pokholenko I, Jerdan R, Kamyshnyi A, Krikunov AA, Potochilova VV, Rudnieva KL, Spiers AJ	PLoS One	10.1371/journal.pone.0270983	2022
Transcriptome	Burkholderia paludis sp. nov., an Antibiotic-Siderophore Producing Novel Burkholderia cepacia Complex Species, Isolated from Malaysian Tropical Peat Swamp Soil.	Ong KS, Aw YK, Lee LH, Yule CM, Cheow YL, Lee SM.	Front Microbiol	10.3389/fmicb.2016.02046	2016

References

#357	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 681
#20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )
#20216	Curators of the HKI: Collection Description Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut (HKI) . Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut (HKI):
#20218	Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )
#37328	; Curators of the CIP;
#45338	Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 10785
#66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .
#68368	Automatically annotated from API 20E .
#68374	Automatically annotated from API ID32E .
#68382	Automatically annotated from API zym .
#121888	Collection of Institut Pasteur ; Curators of the CIP; CIP 53.153
#124043	Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy .
#125438	Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 )
#125439	Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 .
#126262	A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 )

Rate our new design

Content

About us

Klebsiella pneumoniae (DSM 681, ATCC 10031, NCIB 9111)

Name and taxonomic classification

Morphology

Cell morphology

Culture and growth conditions

Culture medium

Culture temp

Physiology and metabolism

Oxygen tolerance

Antibiotic susceptibility testing

Spore formation

Compound production

Metabolite utilization

Antibiotic resistance

Metabolite production

Metabolite tests

Enzymes

API 20E

API zym

API ID32E

API biotype100

Isolation, sampling and environmental information

Interaction and safety

Risk assessment

Sequence information

Genome sequences

Genome browser: GCA_900451675

16S sequences

Genome-based predictions

Predictions

Literature

Literature

References

BacDive

Help

Social Media